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DESIGN AND SYNTHESIS OF BORONIC ACID-MODIFIED NUCLEOTIDES
FOR FLUORESCENT SENSING AND CELL IMAGING

by

XIAOCHUAN YANG

Under the Direction of Professor Binghe Wang

ABSTRACT

With the rapidly increasing interest in the field of glycomics, which is the
comprehensive study of the roles carbohydrates play in a living system, urgent need for
developing quick and highly selective carbohydrate sensors is growing. The boronic acid
group, with its electron-deficient structure (6 valence electrons with an open shell), acts
as a Lewis acid with high intrinsic affinity towards Lewis bases such as fluoride, cyanide
and hydroxyl groups. Specifically, formation of a 5- or 6- membered ring between the
boronic acid moiety and a1,2- or 1,3-diol in aqueous solution has been fully explored as
a strategy of carbohydrate sensor design. Along this line, those binders were termed as
“boronolectins” because of their similar functions as lectins.
One challenge in developing boronic acid-based carbohydrate sensors is to
enhance the discriminating ability among various carbohydrate analytes with diverse
building blocks and complex linkage patterns. One approach is using polypeptide or

oligonucleotide as a backbone or scaffold with functionalized boronic acid moiety to
create a molecular library, and then selecting binders with favorable properties.
The work presented here includes three general research parts: synthesis of a
naphthalimide-based boronic acid-conjugated thymidine triphosphate

(NB-TTP),

fluorescence property studies of NB-TTP incorporated DNA (NB-DNA), and cellular
imaging studies using NB-TTP:
1) 4-Amino-1,4-naphthalimide (Nap) was chosen as the fluorophore because of its
relatively long excitation and emission wavelengths, and stability. The synthesis of
naphthalimide-based boronic acid (NB) followed similar route as previously published
work. Tethering of boronic acid moiety and TTP was accomplished through
Cu(I)-catalyzed azide-alkyne cyclization (CuAAC), known as click chemistry. The
synthesized NB-TTP showed fluorescence enhancements at long wavelength (λem: 540
nm) upon sugar addition.
2) NB-TTP was incorporated into DNA through Klenow fragment-catalyzed primer
extension reactions. Different DNA sequences were designed with varying number and
spacing for NB-TTP incorporation. The preliminary study provided certain insight into
several factors that affect the fluorescent properties of different NB -DNA.
3) NB-TTP was added into Hela cell culture medium to study its cell imaging
properties. With the observation under fluorescent microscope, it was demonstrated that
NB-TTP showed good cell membrane permeability and significant accumulation in cell
nucleus.
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1. INTRODUCTION
1.1 . Glycomics study and natural carbohydrate sensors
With the completion of the Human Genome Project and the mapping of
approximately 20,000-25,000 genes in the human genome,1-3 the world is entering into a
post-genomics era of investigating how genes function in a coordinated fashion in vivo
and in response to outside environment. It is well known that after transcription and
translation from the genomic DNA sequences, the expressed proteins or peptide
sequences sometimes undergo further modifications (post-translational modification,
PTM) in order to gain full function properly.4-7 Glycosylation, the attachment of
oligosaccharide moieties to the protein, is perhaps the most complicated form of
PTM.8-10 In fact, the differences contributed by the various glycoforms are so significant
that the microdiversity of proteins created by glycosylation can determine their functions
and properties.11-15 Collectively, the vast diversity of glycans arises from its non-template
driven biosynthetic routes, a lack of proof-reading machinery, and a large number of
tissue-specific isoforms of glycosyltransferase and glycosidase.16-17 Differences in
sequence, composition and branching patterns also provide the chemical basis for the
structural complexity of glycans. Such complexity rivals or exceeds that of proteins and
nucleic acids. On one hand, the inherent chemical heterogeneity and structural diversity
makes it convenient for cells to coordinate together and be individual and specific in the
whole body context. On the other hand, it also creates a great challenging scenario in the
research field of glycosylation. Thus, there is an urgent need for developing tools to
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detect and differentiate so many different forms of glycans. Currently, the word “glycan”
refers

to

a

general

term

including

oligosaccharides,

polysaccharides

and

carbohydrates.17 The term of “glycomics” also emerged correspondingly, which is
defined as the comprehensive study of the biological roles glycans play in living
organisms, as in parallel with terms like genomics, proteomics and lipidomics.
1.1.1 Brief introduction of glycan structures
Briefly, there are nine monosaccharides used by mammals in enzymatic glycosylation
processes. These are galactose, glucose, glucuronic acid, fucose, mannose,
N-acetylgalactosamine, N-acetylglucosamine, sialic acid and xylose (Figure 1.1).17 For
glycans on cell membranes or extracellular compartment in the forms of glycoproteins
and glycolipids, their assembling is through the Golgi apparatus where the glycan
oligomers elongate and branch.12,18 There are three major glycosylation patterns of
protein: O-glycan, N-glycan and glycosaminoglycan. Specifically, N-glycans are attached
to the asparagine residues in the Asn-X-Ser/Thr motif of proteins.19-21 O-Glycans are
linked to either Ser or Thr residues.19,22 Glycosaminoglycans are also Ser or Thr
anchored but in linear instead of branched, and often highly sulfated oligo-forms.23-25
Glycosylation on lipids is in the form of sialic acid-bearing gangliosides.26-27 Besides
those glycosylations that happen through the Golgi apparatus secretory pathways, many
cytoplasmic and nuclear proteins are glycosylated by N-acetylglucosaminidase in
cytoplasm. N-Acetylglucosamines attached to Ser or Thr residues (O-GlcNAc) of those
proteins are found to be a very important PTM regulated for many mammalian cell types’
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viability, probably as nutrient sensors or protein turnover regulation factors.28-31 Again, all
the glycosylation patterns with α orβanomers linking through 1,2 (donor) → 2,3,4,6
(acceptor) glycosidic bonds contribute to a repertoire of tremendous number of glycan
structures.17
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Figure 1.1. Monosaccharides used in mammalian enzymatic glycosylations

1.1.2 Brief introduction of glycosylation functions
Glycosylation in animal body functions is important. For example, in transgenic mice
with GlcNAcT-1 glycosyltransferase deficiency, the embryos showed severe defects in
the cardiovascular system and other morphogenic abnormalities.32-33 In general, there
are several biological processes that involve glycosylation. For example, cell-cell
adhesion mediated by glycan-protein interactions is critical for trafficking lymphocytes,
neutrophils, CD4+ T cells, natural killer cells and other immuno-responsive cells to the
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site of inflammation;34-37 the mammalian immunoreaction is directed by molecular
recognition

mechanisms

including

a

key

fucose

linkage

on

sialyl-Lewis

X

oligosaccharide;38 self/non-self recognition through discrimination of pathogen glycans
by mammalian cells is responsible for the initiation of some immunoreactions;39-40
pathogen-associated molecular patterns (PAMP), once recognized and bound, can
initiate phagocytosis by macrophages to clear up the invading organisms.41-45 Glycan
recognition is also responsible for the body’s metabolism regulation, such as turnover of
endogenous glycoproteins. One case in point is the hepatic asialoglycoprotein receptors
(or hepatic binding proteins, HBP), which can bind to and internalize the glycoproteins
with fewer or without any sialic acid linkages.46 In mice with decreasing thrombosis
resulting from defective sialytransferase expression, both platelets and the von
Willebrand factor (vWF) glycoproteins are targets for asialoglycoprotein receptors.47
Moreover, some glycosylation recognitions are involved in cellular receptor activation
and signal transduction processes. For example, specific heparan sulfate, as one kind of
glycosylaminoglycans, can bind to fibroblast growth-factor receptors and induce receptor
dimerization and activation.48 It is also found that some morphogenesis and
organogenesis

in

early

embryo

stages

can

be

regulated

through

glycosylaminoglycan-receptor binding.49 Of course, listing all the examples of
glycosylation importance will be laborious work and not practical. Illustrating a few
examples above helps to highlight the meaning and need for developing tools for glycan
sensing and study.
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Given the importance of glycosylation in normal mammalian body functions, it is
conceivable that abnormality of certain glycosylation patterns could result in dysfunction
or even disease of human body. For example, the lack of dolicol-oligosaccharide
precursor resulting in a decrease in N-glycosylation frequency is found to be responsible
for congenital disorders of glycosylation (CDG) syndromes of children, many of which
are discovered especially in their early life years.50-52 I-cell disease, resulting from the
failure of mannose-6-phosphate modification of N-glycan in the Golgi body, causes a
protein storage disorder, due to the lack of trafficking signal of hydrolase into
lysosome.53-54 Furthermore, unusual glycosylation patterns serve as good indicators for
specific diseases such as cancer and serve as biomarkers in clinical diagnosis.55-60 In
one case, elevated T-antigen levels (truncated O-glycan) were correlated with the
prognosis of low survival rate of certain cancer patients.14,61 Another example is the
prostate cancer antigen (PSA) from tumor cells, which contains a higher level of fucose
and absence of sialic acid compared with PSA from normal cells.62-65 Also, different
glycosylated forms of hCG can be diagnostic biomarkers for cancer, Down syndrome, or
pregnancy failure.66-67 Specifically, hyperglycosylated hCGs (hCG-H, also known as
invasive trophoblast antigen-ITA), are very different from normal hCG (human chorionic
gonadotropin) in terms of both functions, origins, and glycosylation paterns. While
hCG-H is essential for successful human implantation, it is also an invasive promoter in
choriocarcinoma.68 One last but not least example is human RNase 1, which has
completely different glycosylation patterns when secreted by pancreatic tumor cells
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compared with those by normal cells.58,69-70 For a more comprehensive compiling of
glycan-based biomarkers, some excellent reviews are recommended.71-73 However,
even with those well-documented glycosylation related diseases, the discovery process
is more serendipitous than well-planned.17 Commonly used protein separation methods
through isoelectric focusing and electrophoresis are not able to catch most glycosylation
defects. Thus, developing tools that can primarily focus on the glycosylation
microdomain (sweet spots) should have great meaning and implication in clinical
practice.
1.1.3 Conventional tools and methods for glycosylation studies
Conventional chemistry analytical approaches, such as mass spectrometry,74-79
HPLC80-81 and NMR,82-84 have been used together with computational informatics as an
integral method for glycan primary structure characterization.16,85-86 As powerful as those
essential tools are, they suffer from the shortcomings of time consuming, and the need
for advanced expertise and large sample amounts (for NMR). Besides, analysis of the
glycan moieties using those methods requires removal of the saccharides from proteins
and seperate characterizations. Due to the inherent heterogeneity nature of glycans,
systematic analysis of a large number of glycans demands a more efficient approach.
The above-mentioned proteins that bind to N- or O-glycans and mediate various
biological processes are generally termed glycan-binding proteins (GBP). So far, three
major classes of natural GBPs have been identified in mammalian system: C-type lectins,
siglecs and galactins.9-10,16 The C-type lectins are so named because of their
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requirement of Ca2+ for proper functions.87-88 C-type lectins are further divided into three
sub-classes: endocytic lectins, collectins and selectins. Previously discussed hepatic
binding proteins (HBP) are the prototype of endocytic lectins, specific for
galactose/N-acetylgalactosamine moiety.46,89-90 Endocytic lectins are all transmembrane
proteins with extracellular carbohydrate recognition domain (CRD).88 In contrast,
collectins are soluble proteins with a cysteine-rich amino terminal and a CRD carboxyl
terminal.91-92 Mannose-binding proteins (MBP A and MBP C) are typical examples of
collectins.93-96 The third subclass, selectins are so named because of their mediation in
selective contact between cells. Three members of selectins, E-selectin, P-selectin and
L-selectins, are all membrane bound proteins with CRD located at amino terminal
part.97-101 In total, there are hundreds of lectins identified and characterized, among
which about 60 of them are commercially available from companies like Sigma-Aldrich
and Fisher Scientific.71 Due to the flexibility around glycosidic linkage, oligosaccharides
exist with highly dynamic conformations. The lectin-glycan binding affinity is quite
structure-dependent so that saccharides with different chemical compositions but similar
topographic properties can bind to the same lectin.88 In contrast, different lectins for the
same saccharide could focus on separate regions of the saccharide structure. However,
once bound by lectins, specific conformation of the glycan is locked and fixed and the
rotational freedom around glycosidic linkage is reduced. Thus, lectins bind saccharides
in a reversible and specific way, but they all have cross-reactivity issues.71,88 Different
from C-type lectins, siglecs are a subgroup of immunoglobulin superfamily, termed I-type
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lectins.102-103 The N-terminal of siglecs specifically recognizes sialic acid-containing
ligands. The third type of GBPs, galectins are so named because their selective affinity
towards galactose-containing ligands on cell-surface.104-106
All three types of GBPs are involved in previously discussed cell-cell adhesion, cell
trafficking and signal transduction processes through target glycan bindings. Among
them,

lectins

are

the

most

widely

used

tools

in

glycan

research.34,37,44,60,88,91-92,99,102-103,105-110 Binding between lectin and carbohydrate happens
on the shallow cavity of lectin surface and primarily relys on hydrogen bond formations
and hydrophobic interactions.71,88 Thus, single lectin-glycan interaction is very week with
Kd at the mM level. Tight binding is achieved through cooperative multivalent interactions
of lectin towards oligosaccharides (Kd to μM range),111-112 while lectin-monosaccharide
interaction remains at the same level. Application of lectins in glycosylation research has
been achieved in recent years through a lectin-microarray method.108-110,113 Basically,
different types of selected lectins are immobilized on the array surfaces and analytes
with fluorescence labeling are applied on the microarray. Through analyzing the binding
profiles generated on the arrays, each glycosylation pattern has one corresponding
fingerprint profile. Through such method, general glycan information such as N- or
O-glycosylated form, mannose and fucose content and sialylated level could be acquired.
Furthermore, even real-time monitoring of glycosylation pattern changes was achieved
using this approach.109
Given the efficiency of lectin microarray in glycan detection, the technique is still
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limited by the availability of lectins. First of all, only about 40 commercially available
lectins can be obtained conveniently, compared to hundreds and thousands of glycan
targets are on the list of being analyzed. Second, the cost is still much higher using
biological generated lectins than using usual chemically synthesized sensors.
1.1.4 Conclusion
In general, carbohydrates are very important in glycosylation modification of proteins.
Acurate detection and characterization of those glycans have great implication in terms
of both fundamental biological research and clinical diagnostic applications. However,
the complexity and numerous varieties of the carbohydrate analytes constitute an inviting
challenge for people to develop rapid and efficient research tools in area of carbohydrate
recognition. Lectins as natural carbohydrate binders showed great promise in their high
affinity and somehow selectivity towards oligosaccharides sensing. However, in order to
address the issues of their high cost, limited availability and certain degree of cross
reactivity, there is an urgent demand for developing artificial lectin-mimetics that are low
in cost, easy to make and highly selective. For such purpose, great amount of efforts
have been carried out in developing synthetic lectin-mimetics using chemical
approaches, among which one specific class is the boronic acid-based carbohydrate
sensor utilizing the intrinsic affinity of boronic acid towards carbohydrate diols.
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1.2 Boronic acid: a powerful tool to detect carbohydrates
1.2.1 Brief introduction of boronic acid chemistry
As introduced in the previous chapter, the importance of glycomics studies requires
the development of novel powerful tools to assist and complement currently using
biological approaches. Under the “biology-driven chemistry” impetus, great effort has
been undertaken to develop artificial sensors for carbohydrate. Besides the need in
glycosylation research, those sensors may even be further applied for clinical diagnostic
and therapeutic purposes. In terms of their functions, those sensors act as lectin mimics.
In general, there are two chemical design strategies:

boronic acid-based and

non-boronic acid-based sensors. The boronic acid-based lectin mimics using the strong
and reversible interactions between boronic acids and hydroxyl groups as recognition
moieties are termed “boronolectins”.114 In contrast, most of the non-boronic acid-based
lectin mimics rely on hydrogen bond, hydrophobic and ionic interactions in building up the
intrinsic affinity.71,115-116 It should be noticed that in an ideal application situation, the
carbohydrate sensing should be best performed in an aqueous environment. Most of the
non-boronic acid lectin mimics designed so far only function under aprotic solvent
system.116-118
Since for chemosensing purpose the solvent system is not a major issue, it is
understandable since those interaction studies could provide insightful information about
non-covalent interactions between carbohydrates and sensors, which is the strategy that
nature adapts in lectin-glycan binding processes. One noticeable exception of them is
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the elegant work by the Davis group. In this case, a binding cavity was created to
accommodate sugar moiety with parallel aryl rings as the roof and floor for hydrophobic
interactions, and with four amide linkers as pillars for hydrogen bond interactions (Figure
1.2).116,119 Thus, the sensor designed spatially complement saccharides possessing axial
CH groups (CH-π interaction) and equatorial hydroxyl groups (hydrogen bond interaction)
(Scheme 1.1). Then dodecacarboxylate side chains were linked to sensor to provide it
with good solubility for entering into the aqueous phase.120 The sensor and
β-N-acetyl-D-glucosaminyl (β-GlcNAc) have a association constant of 630 M-1,121 which
was strong enough to rival natural β-GlcNAc lection, wheat germ agglutinin (WGA).
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Meanwhile, there are many water soluble boronlectins designed, which have promise
for potential biological applications in the future. The nature of biological studies and
clinical diagnostics makes water solubility a primary requisite of sensing tools. Due to
the widely spread effort in using boronic acid as a carbohydrate recognition motif from a
great many active labs including that of Strongin, Shinkai, Czarnik, Anslyn, Lavigne,
Heagy, Duggan, Hall, Asher, James, Wang, Lakowicz, Geddes, Norrild, Hindsgaul,
Singaram, Tao, Lowe, Eggert, Smith, Okano, Taylor, Takeuchi, Ishihara, Katterle,
Sporzynski, Freund, Mattiasson, Yoon, Scheller, Tuncel, Anzai, Houston etc,122-123 it
would be necessary to get a comprehensive understanding of the chemistry nature of
boronic acid first.
The boron atom of boronic acid in its neutral form is in sp2 hybridization status with 6
valence electrons forming 3 pairs in a trigonal plane and a vacant p orbital perpendicular
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to it. Thus, the electron deficiency nature of boronic acid makes it a ready lone pair
electrons acceptor to fill its open shell and achieve a stable octet state. Because of such
unique electronic structural property of the boron atom, boronic acid has a high tendency
to react with a Lewis base such as hydroxyl, amino, and carboxylate groups.124-131
Boronic acids are also known to bind with simple Lewis bases such as fluoride132-135 and
cyanide.136-137 All these features have stimulated great interest in utilizing boronic acid as
a key functional group for designing receptors and sensors for carbohydrates,138-143
hydroxyacids,144-147 amino alcohols,127,148-149 cyanide,136-137 and fluoride.132-135,150
Among all the boronic acid sensor applications, we are particularly interested in the
carbohydrate sensing area. In fact, boronic acid’s specialty in the carbohydrate
recognition field is widely acknowledged by chemists, especially due to its unique high
affinity towards 1,2- or 1,3- carbohydrate diols. For a detailed discussion of boronic
acid-carbohydrate complex formation, it will be helpful to begin with an illustration of
several features of the boronic acid-diol interaction. Firstly, the acidity of a boronic acid
arises differently from that of a conventional BrØnsted acid, which releases a proton.
Taken phenylboronic acid (PBA, 1, Scheme 1.2) as an example. In a protic solvent such
as water or alcohol, solvent molecules will first react with boronic acid by donating lone
pair electrons to occupy the boron p orbital, which converts the hybridization state of B
from sp2 to sp3. The coordination complex will then release one proton to form an anionic
tetrahedral phenylboronate (2, Scheme 1.2). Since the deprotonation of the boronic acid
hydroxyl group is much harder (higher pKa), the acidity of a boronic acid actually results
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from its Lewis acidity per se. In an aprotic solvent, boronic acids act as a pure Lewis acid.
For this reason, boronic acids are frequently used as Lewis acid catalysts and chelating
agents for reaction controls in organic synthesis.151 Secondly, the boronic acid is
transformed to its corresponding boronic ester once it reacts with carbohydrate diol (3,
Scheme 1.2). The driven force is partially due to the 5- or 6- membered ring formation,
depending on whether it’s 1,2- or 1,3- diols respectively. It should be noticed that the
acidity of the boronic ester still remains due to the existence of the boron open shell. The
boronic ester can react with a protic solvent molecule, release a proton, and generate
the boronate ester anion (4, Scheme 1.2) much the same way as a boronic acid.
Determined by the dihedral angles and ring strains of the formed complex, boronic ester
acidity is also affected by the stabilizing energy of sp3-boron accordingly. In most of the
cases, boronic acids are more readily binding towards linear diols and diols on
five-membered rings than diols on six-membered rings.71 Exceptions do exist such as
pinandiol,152-154 which is a six-membered ring and binds boronic acid very tightly. The
key is still the dihedral angle. Smaller O-C-C-O dihedral angles favor binding by driving
the reaction equilibrium to forming more stable anionic boronate esters with tetrahedral
geometry, making boronic esters usually more acidic than boronic acids. This also
partially explains the reason for the high affinities that catechols display towards boronic
acid. One useful method for determining boronic acid-diol binding constant using Alizarin
red S (ARS) was developed by our group based on competitions,155 which will be
discussed later. Thirdly, because of the intrinsic Lewis acidity of both boronic acids and
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boronic esters, it is conceivable that the boronic acid-carbohydrate binding affinity will be
affected by boronic acid/diol pKa values and solution pH. Most of the time, low boronic
acid pKa values and high pH conditions are commonly believed to favor binding.126
However, this is not always the case. Optimal binding conditions involve the interplay of
the pKa values of the boronic acid and diol, solution pH, and the nature and concentration
of the buffer solution.114,126 It was found that the optimal binding pH is often between the
pKa values of the boronic acids and diols. For example, the optimal pH for the binding
between ARS and a phenyl boronic acid is close to or below 7.4,126,155 while in other
cases of boronic acid-carbohydrate binding the preferred binding pH is within basic
condition. Beside those, several other factors such as solvent system, buffer composition,
temperature and steric hindrance can also affect intrinsic affinities of diols for a boronic
acid. 114,125-126

OH
B
OH
1
Ktrig

HO

H2O

H+

OH
B OH
OH

H2O

H+

2
Ktet

OH

H2O
O
B

3

HO

OH

H2O
H2 O

H+

H2O

H+

O

O
B
O
OH
4

Scheme 1.2 Binding of phenylboronic acid with a diol

16

From the above discussions about boronic acid-diol binding, it is easy to see that with
all the factors affecting the binding process, not all boronic acids have the same affinity
toward a given diol and not all diols have the same affinity for a given boronic acid. Thus,
for the design of boronic acid-based carbohydrate sensors, taking multiple factors as a
whole picture into consideration with detailed analysis is required for building binders of
high intrinsic affinity and selectivity with the best chance for success. For measuring and
comparing the boronic acid-diol binding affinities, binding constant Ka or dissociation
constant Kd is often used. However, in this case, binding constant Ka is really referred to
as the apparent overall binding constant, Kapp, which does not considerate the ionization
states of boronic acids or boronic esters (Scheme 1.3).125-126 From the overall binding
equation, the real binding event happens among all four molecular forms as trigonal
boronic acid 1, tetrahedral boronate 2, trigonal boronic ester 3 and tetrahedral boronate
ester 4 (Scheme 1.3). Using either binding constant Ktrig (equilibrium constant between
the trigonal forms of boronic acid and boronic ester) or Ktet (equilibrium between the
tetrahedral boronate form and boronate ester) will not be representative enough to
describe the process in a general way.114 To simplify the situation but not leaving out the
essential information, an overall equilibrium to represent the binding between a
phenylboronic acid and a diol is used without digging up the exact ionization status
distribution of all forms. After all, Kapp is directly related to the binding/dissociation
equilibrium and informative enough for binding affinity evaluation.
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Scheme 1.3 Overall binding equilibrium of phenylboronic acid with a diol
In conclusion, this chapter has discussed about the basic chemistry of boronic acid
and some fundamental features of boronic acid-diol binding process. Those background
knowledge and information should have laid a good foundation of rational design and
synthesis of boronic acid-based carbohydrate sensors.
1.2.2 Small molecular boronic acid sensors for carbohydrates
Due to the tremendous development in the glycobiology and glycomics areas,
carbohydrate sensing represents an area of enormous biological importance, which
requires a large number of tools that allow for high affinity and high specificity
recognitions. Binders and sensors for such glycans are very useful as potential
diagnostic tools and therapeutic agents. In the boronic acid-based carbohydrate sensing
field, there have been hundreds of publications. Instead, the focus will be on key issues
and approaches to consider in designing and selecting boronic acid sensors/binders for
carbohydrates and catechols.
The ability for the boronic/boric acid group to bind “tightly” to carbohydrates was
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recognized over a century ago. In the 1940’s and 50’s, there were a number of excellent
papers examining such interactions in detail.124,156-159 In the early 1990’s Czarnik138,160
and Shinkai161 started the modern wave of interests and activities in using the boronic
acid moiety for the design and synthesis of sensors/binders of carbohydrates. Now
boronic acid-hydroxyl group interactions are probably the most widely used single pair
functional group interactions in the design of sensors and “binders”.71,114,162
In applying boronic acid-nucleophile interactions for the design of boronolectins, three
factors need to be kept in mind: relatively low affinity, reversibility, and pH dependence. If
these factors are not considered, one could be led to propose applications that have little
theoretical chance of success. The pH dependence has been studied and reviewed
extensively71,114,126,163 and will not be discussed again. The reversibility in binding is ideal
for sensor design where “regeneration” is necessary, but may not be desirable in other
applications. As with any binding event, the “devil is in the detail,” which is the binding
constant. For example, the apparent binding constant between phenylboronic acid and
glucose is only about 5 M-1 at near physiological pH.163 For fructose, mannose, galactose,
sialic acid, mannitol, and sorbitol, the apparent binding constants are 160, 13, 15, 21, 120,
and 370 M-1 respectively. Such numbers are far greater than what can be achieved with
single pair functional group interactions involving, e.g., hydrogen bond, ionic interactions,
and ion-dipole interactions in an aqueous environment. However these numbers also mean
that at below mM concentrations of these sugar, binding is minimal. Therefore, single
boronic acid interactions are rarely useful as “sensors” except in rare cases164 and with
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boronic acids that have enhanced affinities.165-166 On the other hand, the “bulk” properties of
boronic acids can be used for crude separation purposes with one caveat that one has to
keep in mind that the intrinsic affinity differences of a boronic acid for different
carbohydrates may bias the results if one is not careful. When the boronic acid moiety is
used in sensor/binder design for carbohydrates, inevitably additional interactions, either a
second boronic acid or other groups, are needed for reinforcement of the interactions. Of
course, the three-dimensional scaffold that holds the appropriate functional groups is also
very important.
Another important issue in using boronic acid as the key recognition moiety for the
design of lectin mimics (boronolectins) is the availability of boronic acids that change
spectroscopic properties upon bindings. The incorporation of such spectroscopic reporter
compounds allows for the generation of an intrinsic signal during binding and can greatly
simplify detection. Along this line, many such reporter compounds have been
reported.161,167-178 Detailed discussions are not presented here. Readers are referred to
several extensive reviews that have covered this topic very thoroughly.71,114,179 In such an
approach, also need to be considered are the wavelengths of the fluorophores, the
requirement for large intensity changes for quantitation work, the requirement for the Kd to
be comparable to the detection concentration, and covalent immobilization of the boronic
acid in the solid-phase matrix. In this chapter, we would like to present a discussion of
several small molecular boronic acid sensors for carbohydrate detection, most of which
involved fluorescence change as reporting signal for binding evaluations.
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Norrild reported a bisboronic acid-based sensor (5, Figure 1.3) capable of selectively
binding glucose.180 In this case, two pyridylboronic acids were functionalized at both sides
of anthracene as the bisdentate recognition moieties. The positive pyridinium groups serve
to increase both water solubility and binding affinity of the sensor at neutral pH. NMR
studies showed that glucose was bound at the 1,2;3,5-OH positions in its α-D-furanose
form by the sensor (Figure 1.3). The sensor showed about 1.9- and 1.8-fold fluorescence
intensity increases upon glucose and galactose addition (10-5~10-1 M, pH 7.4, λex: 377 nm,
λem: 427 nm), respectively, while fructose addition resulted in no more than 10%
fluorescence intensity changes under similar condition. The glucose-sensor binding
constant (Ka) was calculated to be 2.5×103 M-1 using this method.
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Figure 1.3 Complex of bisdentate boronic acid 5 with α–D-furanose glucose 1,2;3,5-OH
groups by Norrild

The Shinkai lab has successfully synthesized another boronic acid-based bisdentate
glucose sensor (6R or 6S, Figure 1.4), with chiral discrimination ability.181 With a
1,1’-binaphthyl moiety as the chiral and fluophore building block, saccharide-boronic acid
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binding could affect the fluorescence intensity through photoinduced electron transfer
(PET) involving intramolecular boron-amine interactions. The mechanism of such
interactions

has

recently

been

extensively

studied.172,182-183

Among

the

monosaccharides tested, D-glucose induced a maximum of 4-fold fluorescence intensity
increase of 6R while only a 2-fold increase was observed with L-glucose (10-5~10-1 M, pH
7.77, λex: 289 nm, λem: 358 nm). The situation was reversed with the 6S form, in which
L-glucose induced twice the fluorescence intensity increase than D-glucose. Similar
phenomenon was observed with fructose. Mass spectrum results and binding constant
calculation supported a 1:1-complex binding pattern. Competition studies showed that
D-glucose could be recognized by sensor 6R in the presence of L-glucose (10-3 M). Thus,
it was concluded that selective chiral discrimination of monosaccharide enantiomers was
achieved successfully in this case.

N

OH
B
OH

OMe
OMe
N

OH
B
OH

6R or 6S
Figure 1.4 1,1’-Binaphthyl bisdentate boronic acid as chiral glucose sensor by Shinkai
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The Lakowicz group has synthesized a series of N-(o-, m-, p-boronobenzyl)6-methoxyquinolinium bromide (o-, m-, p-BMOQBA) (7, Figure 1.5) for potential tear
glucose detection in contact lens.184-185 Due to electrostatic interactions between the
positively charged quaternary nitrogen and the negatively charged boronate ester upon
sugar binding, fluorescence was observed to decrease by 12-15% in the presence of 2
mM glucose (λex: 345 nm, λem: 450 nm, pH 7.5). These glucose probes were reported to
have good water solubility, high quantum yields (Ф: 0.5), function near physiological pH
and show color changes in the visible region. The author suggested that tear glucose
(0.5~5 mM in diabetic patients, ~10 fold lower than blood glucose level) sensing would
be favored for its non-invasiveness and continuous monitoring compared with traditional
blood glucose monitoring methods.
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Figure 1.5. N-(o-, m-, p-boronobenzyl)-6-methoxyquinolinium bromide 7 by Lakowicz

Among some of the computational chemistry-guided carbohydrate sensor design
efforts, the most prominent example is the work of Drueckhammer,186 which took a
vector-based approach for the design of boronic acid-based sensors for glucose in its
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pyranose form (Scheme 1.4) instead of the furanose form, which is the binding form with
many other diboronic acid compounds reported in the literature.141,180,187-192 The work
started with the virtual “reaction” of glucopyranose with two phenylboronic acid moiety at
the 1,2- and 4,6- positions. Then the system was subjected to quantum mechanics
geometry optimization. The two phenylboronic acid moieties after optimization were
considered as vectors to allow for the computational search, using the CAVEAT program,
of rigid scaffolds that allow for the proper arrangements and orientation of these two
boronic acid vectors for optimal complementarity. Compound 8 was an example
candidate sensor for D-glucopyranose. As designed, 8 was able to bind D-glucose with
high affinity and binding resulted in a decrease of fluorescence intensity. Indeed, the
binding was in the pyranose form as demonstrated by 1H-NMR. The selectivity of the
sensor for D-glucose versus other saccharides including D-galactose, D-mannose, and
D-fructose was also studied. The sensor showed at least a 400-fold higher affinity for
glucose (Kd: 2.5 × 10-5 M) than for the two other saccharides, D-galactose (Kd: 1.0 × 10-2
M) and D-mannose (Kd : 1.6 × 10-2 M). The high selectivity for D-glucose was attributed
to the proper scaffold of the sensor, which positioned the two boronic acid moieties
complementary to the diol pairs of glucose. Compound 8 represents a very successful
example of using de novo computational design for the construction of carbohydrate
sensors. Very importantly, the same general approach should be applicable to the design
of sensors for other saccharides and organic molecules.
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Scheme 1.4. Vector-based approach for the design of boronic acid-based sensor 8
for glucose in its pyranose form by Drueckhammer

Different from those carbohydrate sensors with boronic acids directly attached to
fluorphores, Singaram and coworkers developed a bimolecular sensing system
comprising an anionic fluorphore molecule and a boronic acid modified quencher
seperately.147,193-194 Inspired by the methyl viologen quenching fluorescence of
8-hydroxypyrene-1,3,6-trisulfonic acid trisodium salt (HPTS, Scheme 1.5), Singaram lab
firstly developed the system by incorporating two boronic acid moieties into viologen
quencher to make the 4,4’-N,N’-bis(benzyl-2-boronic acid)-bipyridinium dibromide
(4,4’-o-BBV, Scheme 1.5) quencher.193 It was proposed that the fluorescence quenching
mechanism was mediated through electron transfer process between anionic HPTS and
cationic viologen moiety complexed by electrostatic interactions (Scheme 1.5). Once
carbohydrate binds to BBV, the tetrahedral anionic boronate formation will transform the
viologen into zwitterionic neutral form, thus diminishing the HPTS-BBV electrostatic
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interaction and reducing the fluorescence quenching process. It was reported that
addition of glucose (360 mg/dL) could result in two fold fluorescence increase (λex: 461.8
nm, λem: 511nm) of the 4,4’-o-BBV/HPTS (3×10-4 M/1×10-5 M, pH 7.4) solution (Scheme
1.5).193 Further exploration of the BBV/HPTS was carried out through synthesizing a
series of BBV analogues. Among them, 3,3’-o-BBV (Scheme 1.5) stands out for its
remarkable selectivity for glucose (Ka: 1.9×103 M-1) over fructose (Ka: 1.1×103 M-1) and
galactose (Ka: 1.8×102 M-1) in pH 7.4 phosphate buffer.147 It was suggested that the
exceptional selectivity was achieved by binding one glucose molecule with both boronic
acids on 3,3’-o-BBV in a chelating pattern. Besides, the low affinity of 3,3’-o-BBV
towards lactate (Ka: 26 M-1) makes it more desirable in clinical glucose detection.
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Scheme 1.5 Equilibrium of BBV quenching HPTS fluorescence

Another multiple-component system using boronic acids for carbohydrates detection
was the before-metioned ARS system developed by Wang group.155 In this case, ARS
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was utilized as a separate fluorescent reporter and competitively binding toward a
boronic acid in presence of carbohydrate analyte (Scheme 1.6). It was proposed that the
boronic acid-ARS binding increases the ARS fluorescence intensity through removal of
the fluorescence-quenching catechol diol protons. With a good water solubility of ARS
(up to 10-3 M), addition of various arylboronic acids had induced about 20-80 fold of
fluorescence intensity increase of ARS solution, accompanied with a visible color change
from deep red to yellow at pH 7.4. Conceivably, carbohydrates competing with ARS for
boronic acids could result in fluorescence decrease due to the disruption of ARS-boronic
acid complex. It was reported that titrating of fructose into ARS/PBA (10-4 M/10-3 M)
solution could induce 8-fold decrease of fluorescence intensity at 100 mM level. Using
the three-component ARS system, the binding constant (Ka) between PBA and sialic acid
was determined to be 21 M-1 (pH 7.4 in 0.1M phosphate buffer) by the
Benesi–Hildebrand method.195 Thus, it was demonstrated that a general fluorescent
assay method has been established to determine the binding constant between a
non-fluorescent boronic acid and target carbohydrate.
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Among all those carbohydrate detection by boronic acids in solution, some
successful real-world application cases have been reported of using fluorescent boronic
acid for cell surface glycan recognition. In the 1970s, Hageman and coworkers observed
the

interactions

between

boronic

acid

and

cell

surface

glycans.196-198

m-Aminobenzylboronic acid at 0.2 mM was found to inhibit sporulation of Bacillis subtilis
without affecting its vegetative growth.197 Since the culturing cells were highly clumped at
later stage in the presence of a boronic acid and the sporulation inhibition could not be
reversed by diluting the inhibitor, it was proposed that m-Aminobenzylboronic acid might
bind to the cell surface carbohydrate through boronate ester formation. Later on, with
fluorescent boronic acid 9 (Figure 1.6), Bacillis subtilis was visibly fluorescent labeled
and the labeling could be reversed by mannitol solution.196 In addition, it was found that
another synthesized double-headed boronic acid 10 (Figure 1.6) was capable of
agglutinating both type O human erythrocytes and sheep erythrocytes in similar
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pattern.196 It was proposed that the double-headed reagent agglutinate cells through
cross-linking, acting in a similar way as lectins. All such results suggested that boronic
acids can be used to bind cell-surface glycans.
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Figure 1.6 Cell surface binding boronic acids by Hageman

Promising cell-surface glycan binding results were reported of a bisboronic
acid-based fluorescent sensor for selectively labeling sLex-expressing cells (Figure 1.7)
by Wang and coworkers.142,199 The design strategy was based on the idea that with a
proper linker, two boronic acid moieties could be appropriately arranged to complement
the diol/hydroxyl structures on sLex. Shinkai’s anthracene-based boronic acid system
was chosen as the fluorophore in this case, for it showed significant fluorescence
intensity increases upon sugar binding.161,200 Among all the linkers chosen,
para-disubstituted phenyl ring 11a (Figure 1.7) showed the best binding and selectivity
for sLex. Fluorescent cell labeling studies showed that 11a selectively labeled sLex
expressing HEPG2 cells while non-expressing COS7 cells and Lewis Y (Ley, Figure 1.7)
expressing HEP3B cells were not labeled. HEPG2 cells treated with neuraminidase and
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fucosidase resulted in significantly decreased labeling, indicating that both the fucose
and sialic acid residues were required for 11a labeling of HEPG2 cells. A control
bisboronic acid (11b) showed no similar labeling. Small molecule lectin mimics such as
11a can be very useful for cell-specific delivery of imaging and therapeutic agents.
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Figure 1.7 Bisboronic acids 11a and 11b by Wang for sialic Lewis acids binding
1.2.3 Conclusion
In conclusion, based on the fundamental chemistry knowledge of boronic acids, all the
successful cases of carbohydrate detection using small moleculr boronic acids show a
promising scenario of further exploring its application. Nevertheless, one of the most
important contemporary challenges in using boronic acids for the design of carbohydrate
sensors is in the selection of the appropriate scaffold to position the boronic acid and
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other functional groups in appropriate places and orientations in order to afford the
necessary specificity and affinity. Single boronic acid-diol interaction by itself is too weak
to lead to high affinity and selectivity. The situation was improved somehow with
bisboronic acid sensors with proper positioning of the bisdentate moieties. However,
finding a good sensor is a very chance-dependent case and so far only a limited number
of such applications have been reported. Meanwhile, complementing to the rational de
novo design approach of small molecular boronic acid sensors design, template-directed
synthesis and combinatorial library approaches could overcome the problem to some
extent, since no detailed structural information of the analytes are required in buiding
those polymer-based boronic acid sensors.
1.3

Boronic acid sensors based on non-biopolymers

1.3.1 Brief introduction of polymer-based boronic acid sensors
In general, there are two classes of polymer-based boronic acid sensors,
non-biopolymers and biopolymers. Biopolymers like polypeptides and oligonucleotides
serving as scaffold for boronic acid positioning are often created through a combinatorial
approach to yield a large molecular library with high diversity, which is later screened
against

carbohydrate

analytes

to

select

proper

“binders”.

In

contrast,

non-biopolymer-based boronic acid sensors are usually generated through two other
strategies. The first one involves self-assembled monolayer (SAM) functionalized with
boronic acid moieties as glycan trap. This method is often coupled with highly-sensitive
detection techniques such as quartz crystal microbalance (QCM)201 or surface plasma
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resonance (SPR).202 The second approach to construct carbohydrate sensors/binders is
template-directed synthesis such as molecular imprinting technique, which has the
desired feature of not requiring prior knowledge of the carbohydrate 3-dimensional
structures. Details of each approach are discussed in the following sections.
1.3.2 Self-assembled monolayer (SAM)-based boronic acid sensors
Boronic acid-based SAM was constructed by the Fernandez group as an affinity-trap
for glycoprotein horseradish peroxidase (HRP) detection.201 Gold film surface was first
coated with 6,8-dithioctic acid, which was then linked to 3-aminophenyl boronic acid
(Figure 1.8).

Presumably, in binding the carbohydrate moieties of HRP were brought

into the proximity of the boronic acid groups through multiple weak interactions. In QCM
tests, addition of glycosylated HRP caused a ~17 Hz frequency decrease while
deglycosylated HRP only caused a less than 2.5 Hz decrease. The 7-fold difference
indicated that the adsorption on boronic acid-based SAM trap was mediated and
differentiated based on the saccharide portion.
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Figure 1.8 Boronic acid-based SAM glycoprotein trap by Fernandez

SPR was used by the Chen group for glycoprotein detection using boronic acid
SAM.202 Glycated hemoglobin HbA1c, formed by non-enzymatic glycation of the
hemoglobin β chain with glucose on the N-terminal valine, was chosen as the target
because its level can be used as a clinical indicator for chronically elevated sugar level in
diabetic patients. Gold surface was coated with dithiobis(4-butylamino-m-phenylboronic
acid) (DTBA-PBA) SAM. The SPR results showed that the detection limit of HbA1c was
0.01μg/ml and good linear regression was obtained in the concentration range from 0.43
to 3.49 μg/ml (pH 9). Compared with traditional tests,203-204 this method showed
approximately a 1000-fold increase in sensitivity. The SPR sensitivity could be improved
another 5-fold by adding a Lewis base when HbA1c concentration was lower than 50 nM.
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Thus, both high sensitivity and specificity of HbA1c sensing were achieved using this
DTBA-PBA-SAM-SPR method.
1.3.3 Molecular imprinted polymer boronic acid sensors
Among the different template-directed synthesis approaches, molecular imprinting is
especially useful in creating receptor sites for organic molecules including carbohydrates.
Molecular imprinting is a technique first demonstrated in the late 40's by Dickey.205 It
involves 3 steps including: 1) mixing the template/analyte with the functional monomers
and cross linkers at low temperature to allow for complementary intermolecular
interactions; 2) polymerization of the monomers and cross linkers under mild conditions;
and 3) extraction of the template molecules from the polymers, which leaves behind
polymeric sites with memories of the template molecules in terms of size, shape, and
functional group orientations (Scheme 1.7). This technique has been used for the
preparation of selective recognition sites for a wide variety of molecules.206-208 Naturally,
the same method has been used for the preparation of sensors,209 including boronic
acid-based carbohydrate sensors.

mixing template, functional
monomers and cross linkers

polymerization of functional
monomers and cross linkers

Scheme 1.7 Molecular imprinting process

extraction of template
molecules
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Wulff first demonstrated the use of boronic acid compounds in molecular imprinting
for the construction of polymeric cavities specific for certain saccharides.210 D-fructose
and D-galactose were used as the template compounds. Specifically, these sugars were
first conjugated with 2 equivalent of VPB ((4-vinylphenyl)boronic acid), presumably at
2,3;4,5-OH of fructose and 1,2;3,4-OH of galactose, to yield their respective
polymerizable monomers. EGDMA (ethylene glycol dimethacrylate) was used as the
cross linker. The polymers prepared were shown to have “memories” of the template
including stereochemical features. For example, the D-fructose-imprinted polymer could
differentiate the D-form from the L-form by a factor of 1.47-1.63. It is interesting to note
that the D-fructose- imprinted polymer could also differentiate L-galactose from
D-galactose by a factor of 1.17 while D-galactose-imprinted polymer could differentiate
L-fructose from D-frucose by a factor of 1.25. It was proposed that the high similarity
between D-fructose and L-galactose as well as L-fructose and D-galactose in terms of
their spatial hydroxyl group arrangements was responsible for the observed cross
reactivities.
Using the same imprinting principle, the Wang lab was the first to synthesize boronic
acid-based fluorescent polymers for saccharides as potential fluorescent sensors.211-212
In such studies, a polymerizable boronic acid monomer (12) was prepared (Figure 1.9).
The anthracene-based boronic acid unit in 12 is known to increase fluorescent intensity
upon sugar binding as reported by the Shinkai lab.139,213 The monomer was first reacted
with D-fructose to form a covalent complex before polymerization in the presence of
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EGDMA as the cross linker. In re-binding studies, the fructose-imprinted polymer showed
significant fluorescent intensity changes (over 100%) upon fructose addition. This
polymer also showed preference for D-fructose over D-glucose and D-mannose, which
was at least twice as large as that determined with the control boronic acid alone.
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HO
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4-nitrophenyl-α-D-mannopyranoside

12
B(OH)2
CH3(CH2)11C C-C (CH2)8CONH
13a

CH3(CH2)11C C-C (CH2)8COOH
13b

Figure 1.9 Boronic acid monomer 12, 13a, cross-linker 13b and
4-nitrophenyl-α-D-mannopyranoside

In yet another example, Kurihara and coworkers214 conducted surface imprinting of
4-nitrophenyl-α-D-mannopyranoside with a polymerizable phenylboronic acid monomer,
(3-(10’,12’-penta-cosadiynamido)phenylboronic acid) 13a and cross-linker 13b (Figure
1.9). 4-Nitrophenyl-α-D-mannopyranoside (Figure 1.9) was used as the template
molecule and the 4-nitrophenoxy group can be used to quantify the binding by UV-visible
spectroscopy. In re-binding studies using both imprinted and control polymers, about
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75% the binding sites of the imprinted surface were occupied by the template, while
about 57% of the non-imprinted surface was covered. This implied that the imprinted
monolayers had an improved affinity for the template molecule.
Molecular imprinting technique is also used in developing boronic acid-based
electrochemical sensors. Usually, thick imprinted polymer layer on the electrode surface
is unfavorable since it hinders analytes diffusion and retards polymer-electrode
communication. The problem can be partially overcome by utilizing thin layer polymer
film electropolymerization on electrodes or on the gate surface of an) device through
radical polymerization.215-217 In such cases, the barrier of analyte diffusion and electrical
contact is minimized. In this regard, the Willner group reported the copolymerization of
acrylamide-acrylamide- phenylboronic acid on TiO2 film for imprinting AMP, GMP and
CMP.217 Charging the boronic acid polymer membrane with nucleotides controlled the
gate potential of the ISFET to allow for detection of each nucleotide. Similar thin layer
boronic acid polymers were constructed by the same group towards various nucleotides
and monosaccharides on Au electrodes, piezoelectric Au quartz crystals, or on the gate
surface of ISFET device.215 Faradaic impedance spectroscopy measurement showed
enhanced selectivity for the template molecules by increasing the cross-linking degree of
the polymer. Most recently, the same group reported fabrication of stereoselective and
enantioselective imprinted polymer for monosaccharides such as D-glucose and
D-mannose.216 The co-electropolymerization of phenol with a 3-hydroxyphenyl boronic
acid-monosaccharide complex on Au support created a thin film of boronate-conjugated
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polyphenol layer coated electrode (14, Figure 1.10). Competitive electrochemical assay
was carried out by measuring the amperometric responses using ferrocene
modified-monosaccharides (15, Figure 1.10) as the redox labels to analyze each
saccharide’s binding affinity. The observed stereoselectivity and enantioselectivity
indicated that rather delicate structural contour was constructed around saccharide
template with boronic acid and other motifs accommodating the hydroxyl groups in a
delicate coordination way.
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Figure 1.10 Boronic acid-contained polyphenols 14 and ferrocene-monosaccharide
redox labels 15

Flow calorimeter was used by the Scheller group218 to study the interactions of
phenylboronic acid-based polymers imprinted with fructosyl valine (Fru-Val), fructose
and pinacol, respectively. Fru-Val is known as the N-terminal glycated amino acid on
glycosylated hemoglobin (HbA1c) (HbA0 is the non-glycated hemoglobin). The imprinted
polymer for Fru-Val was prepared by copolymerizing the complex of Fru-Val and VPB
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with cross linker TRIM (trimethylolpropane trimethacrylate). An exothermic peak signal
was observed when Fru-Val flew through the imprinted polymer in a thermistor. This was
followed by an almost steady state signal.

The intensity of the peak signal increased in

response to Fru-Val in a concentration- dependent manner (up to 5 mM). Control
polymer prepared from the pinacol-VPB complex in the same way didn’t give such
significant signal changes. The apparent imprinting factor (IF), the ratio of binding with
imprinted polymer to that with the control polymer at equilibrium, was determined as 41
by measuring the signal intensity ratios. The temperature increase induced by Fru-Val
interactions with imprinted polymer was 2.4-fold higher than that of fructose-imprinted
polymer interactions and 270-fold higher than that of Val-imprinted polymer interactions.
Thus, a selective Fru-Val MIP sensor was developed and used in calorimeter
measurements.
1.3.4 Conclusion
In conclusion, boronic acids have very unique properties and can be used as a key
functional group in the construction of polymer-based sensors/binders for carbohydrates
or glycans. Non-biopolymer sensors functionalized with boronic acids have been
reported through either self-assebling monolayer (SAM) technique or template directed
synthesis. Neither of these strategies requires prior knowledge of the analytes’ detailed
structural information. Which SAM-based boronic acid sensors primarily rely on sensitive
detection methods such as SPR or QCM, more detection methods are available for
evaluation of molecular imprinted boronic acid polymer sensors such as spectroscopic,
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electrochemical and flow calorimetric methods.
1.4

Boronic acid sensors based on biopolymers

1.4.1 Brief introduction of biopolymer-based boronic acid sensors
Though the discussion of template-directed boronic acid-based sensor work has
been focused on non-biopolymers, one should not feel restricted by this. Such an
approach is in line with dynamic combinatorial library work, which has been proven
useful.219-223 For example, one could envision the linking of two boronic acids through a
tether in a library consisting of multiple boronic acids and linker species. Such a library
could give a large number of bisboronic acid end products. Using combinatorial
chemistry to create a library and then screening the library against the target analytes to
select binders, the library synthesized can be either small molecular ligands,117,224-225
peptide-based boronic acid library (PBLs),226-230 or nucleic acid-based boronic acid
library (NBLs).231-232 Similar with the non-biopolymer version, the biopolymer-based
boronic acid sensors design doesn’t need prior knowledge of the structural and
conformational information of the carbohydrates either. Besides, the chemical synthetic
approaches of biopolymers such as peptides and nucleic acids are very mature and
well-established techniques, which provide more convenience and promise in their
libraries construction. Furthermore, the biological nature of peptides and nucleic acids
also has the implication that such types of boronic acid sensors could possibly be
generated through enzymatic approaches in vitro231 or through cellular machinery in
vivo.233
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1.4.2 Peptide based boronolectin
Recently, there have been some efforts in developing libraries of peptide-based
boronolectins (PBLs), which offer the chance of searching for binders through
combinatorial/diversity-based approaches. Along this line, the labs of Anslyn,226 Hall,228
Duggan,229-230 and Lavigne227 have independently made significant contributions.
In the work from the Anslyn group, arrays of boronic acid derived pentapeptide
receptors (16, Figure 1.11) were constructed for saccharide sensing.226 The
pentapeptide receptors were selected from a random pool of a synthesized library. The
binding affinity of each resin-bound receptor (RBR) was evaluated colorimetrically using
an indicator displacement method first developed in the Anslyn lab. In this case,
bromopyrogallol red (BPR) was chosen as the indicator and Linear Discriminant Analysis
(LDA) was used to process BPR-uptaking data to identify receptor-analyte binding
patterns. Collectively, the unique pattern of each PBL receptor in the chemosensor array
successfully differentiated monosaccharides from disaccharides, and discriminated
isomers within each group. Sucrose and maltose were also differentiated from their
low-calorie counterpart (sucralose and maltitol). Furthermore, sucralose was identified
successfully in Splenda sweetened tea using the same chemosensor array chip with the
LDA data set. It was reported as one of the first assays that supramolecular
pattern-based sensors identified a sweetener in a real world beverage sample.
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Hall and coworkers have developed a triamine-derived triboronic acid library228 using
the combinatorial split-and-pool strategy.234-236 The triamine backbone was synthesized
with tripeptides as the starting point, followed by exhaustive reduction of the amide group
to amine and functionalization of the amine with phenylboronic acid (17a, Figure 1.12).
Lewis-b (Leb) tetrasaccharide, which is a type of cell surface oligosaccharide commonly
expressed on bacteria, red blood cells or tumor cells, was chosen as the binding
target.107,237 Though the study did not yield strong binders, this was an example of
proof-of-concept that a library of receptors containing more than two boronic acid units
was constructed in a controlled manner and individual library members were
successfully characterized by HPLC and ESI-MS after cleavage. Thus, it has the
potential for future optimization and application in screening against saccharides for high
affinity and selectivity recognition. In addition to this example, a resin-to-resin transfer
reaction (RRTR) (of arylboronic acid) was developed by the Hall group and could also be
used in PBL library construction in the future.238
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Duggan and co-workers also prepared solid-supported PBL libraries derived from
4-borono-L-phenylalanine (BPA, 18, Figure 1.13).229-230 The pentapeptide-based
bisboronic acids including a ‘lysine series’ and an ‘arginine series’ (Table 1.1) were
tested for their affinity toward various monosaccharides using competitive binding assay
against Alizarin Red S (50% methanol/50 mM NaHCO3, pH 10.7), first developed by the
Wang lab.163,239 It was hypothesized that the positively charged Lys and Arg residues
could enhance boronic acid-diol binding by ion-pairing with negative-charged boronate
esters. Test results showed that optimal binding towards fructose and glucose was
achieved when two BPA units were adjacent or separated by one amino acid residue;
e.g., the tightest D-glucose binding sequence was Arg PBL 1 (Ka: 3641 M-1) and the
tightest D-fructose binding sequence was Lys PBL 12 (Ka: 4162 M-1). While Arg PBL 4
and 6 showed an 8.3- and 5.4-fold preference for D-fructose binding, Lys PBL 8 showed
a 2.1- fold preference for D-glucose binding. More interestingly, in chiral discrimination
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binding studies, Arg PBL 4 displayed an 8.4-fold preference for L-glucose while Lys PBL
12 showed a 4.3-fold preference for D-glucose. Thus, it was clearly demonstrated that
affinity and selectivity of PBL binding towards saccharide could be greatly influenced and
finely tuned through peptide backbone modifications. The requirement of the PBA
residues to be close to each other to achieve high specificity might also suggested that
binding was a well coordinated and cooperated process.
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NH2
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O

18, p-boronophenylalanine
Figure 1.13 Structure of p-boronophenylalanine 18
Table 1.1 Amino acid sequences of Arg series (1-6) and Lys series (7-12) PBLs by
Duggan
1

N-Ac-BPA-BPA-Ala-Arg-Arg-AHA-SS

2

N-Ac-BPA-Arg-BPA-Ala-Arg-AHA-SS

3

N-Ac-BPA-Arg-Arg-BPA-Ala-AHA-SS

4

N-Ac-BPA-Arg-Ala-Arg-BPA-AHA-SS

5

N-Ac-Arg-BPA-BPA-Arg-Ala-AHA-SS

6

N-Ac-Arg-BPA-Arg-BPA-Ala-AHA-SS

7

N-Ac-BPA-BPA-Ala-Lys-Lys-AHA-SS
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8

N-Ac-BPA-Lys-BPA-Ala-Lys-AHA-SS

9

N-Ac-BPA-Lys-Lys-BPA-Ala-AHA-SS

10 N-Ac-BPA-Lys-Ala-Lys-BPA-AHA-SS
11 N-Ac-Lys-BPA-BPA-Lys-Ala-AHA-SS
12 N-Ac-Lys-BPA-Lys-BPA-Ala-AHA-SS
*AHA=6-aminohexanoic acid, SS= solid support.

Lavigne and coworkers have synthesized a PBL library on aminomethyl PEG-PS
resin and demonstrated its applications in cancer related glycoprotein detection.227 A
12-mer PBL library with a sequence of Cbz-A-(X)10-A-resin (A: alanine, X:
2,3-diaminopropanoic acid, 2,4-diaminobutanoic acid, ornithine, lysine, or alanine) was
synthesized using the split-and-pool method,235-236,240-241 and 2-formylphenylboronic acid
was coupled to the side chain amine through reductive amination. Fluorescein
isothiocyanate (FITC)-labeled glycoproteins, including ovalbumin (Oval), bovine
submaxillary mucin (BSM), and porcine stomach mucin (PSM), were incubated with the
resin-bound PBL library in the presence of 1% BSA (bovine serum albumin) and 10%
glycerol. Using microscopic image screening, beads selective for Oval and BSM,
partially cross-reactive for both BSM and PSM, and completely cross-reactive with all
glycoproteins were observed. In contrast, non-PBL resin did not bind any glycoprotein
and non-glycosylated protein BSA did not significantly bind any beads. Such control
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results indicated that the binding process was PBL- and saccharide-dependent.
Inclusion of PBL resin beads in microtiter plate arrays generated specific color patterns
for binding Oval, BSM and PSM. Thus, although no individual PBL bead was isolated
and characterized, the general results described illustrated the potential of this PBL-resin
array in future diagnostic applications in selective glycoprotein detection.
Different from the above PBLs synthesized through combinatorial chemistry, Schultz
and coworkers developed a method for producing boronate containing protein through
site-specific incorporation of genetically encoded BPA (18, Figure 1.13) in E. coli.233 An
orthogonal tRNA/aminoacyl-tRNA synthetase (aaRS) pair encoding BPA was generated
through altering the specificity of Methanococcus jannaschii (Mj) derived amber
suppressor tyrosyl tRNA (MjtRNATyrCUA)/tyrosyl- tRNA synthetase (MjTyrRS) pair.
Expression experiment results showed that protein was only produced in the presence of
BPA by E. coli with plasmid containing MjtRNATyrCUA and evolved BPA-tRNA synthetase.
The expressed boronate-containing protein was characterized by ESI-MS. The protein
was able to bind polyhydroxyl compounds such as glucamine and sorbitol through
boronate ester formation. In fact, it was also proposed that intramolecular
serine-boronate crosslink was formed in the protein based on the crystal structure of
previously reported original protein and the ESI-MS of the boronate protein. In fact,
boronate ester formation of the protein with polyhydroxylated compound was so
significant that one-step scarless affinity purification of the boronate protein was
achieved with N-methylglucamine conjugated resin. Thus, it was proposed that this
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technology could be applied in the development of boronate containing antibody for
glycoprotein detection or in vivo labeling of boronate protein with polyhydroxylated
reporters.
1.4.3 Nucleic acid based boronolectin
In the area of nucleic acid-based lectin mimics, there have been extensive activities.
For example, the Yu group developed unmodified RNA aptamers for oligosaccharide
(sLex) detection;242 the Anslyn group developed unmodified RNA to fine-tune the
selectivity of an existing small molecule carbohydrate receptor.232 The aptamers
selection process followed essentially those SELEX (systematic evolution of ligands with
exponential enrichment) techniques first developed by the labs of Szostak, Joyce, and
Gold.243-245 Recently, the Wang lab has successfully developed a boronic acid-modified
TTP analogue (B-TTP) that can be enzymatically incorporated into DNA sequence, and
discussed its potential application for aptamer selection in glycoprotein detection and
differentiation.71,231
The Anslyn lab232 used unmodified RNA aptamers to tune the selectivity of a boronic
acid-based receptor with great success. For example, bis-boronic acid 19 (Figure 1.14)
by itself was known to bind citrate (Kd: 5.5 ×10-6 M-1) slightly better than tartate (Kd: 7.1
×10-6 M-1). The immobilized bis-boronic acid receptor 20 on glyoxal agarose beads
(Figure 1.14) was subjected to an RNA pool (N50) SELEX in the presence of 200 µM
tartate. Negative selection was performed on the RNA pool against the immobilized
tris-amine beads 21 as blank control (Figure 1.14) before each round of SELEX to
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increase the selection specificity. The RNA binding to the complex of receptor-tartate
became dominant in the pool from the 7th round. In radio-labeled binding assays, all
seven families of the cloned RNA aptamers showed their preference of binding the
receptor-tartate complex (from 12 to 25%) to the receptor alone (<7%). One specific
sequence was used in the fluorescence binding test of receptor towards analytes. In the
presence of this aptamer, the receptor was able to bind tartate with Kd of 2.1 ×10-4 M-1
while no binding to citrate was observed (Kd >3 ×10-3 M-1). Thus, the selectivity of the
bis-boronic acid was tuned to at least 14-fold higher for binding tartate than citrate in
presence of the selected aptamer. In comparison, the receptor had a 1.3-fold higher for
citrate than tartate in the absence of aptamer.
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Figure 1.14. Bis-boronic acid 19, its immobilized form 20 on glyoxal agarose beads and
blank control tris-amine beads 21 by Anslyn

Based on the general aptamer selection method developed about 18 years ago by
the labs of Szostak, Joyce, and Gold,243-245 the Wang lab are on the effort of developing
a methodology of using boronic acid modified DNA to select aptamers that can recognize
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an intact glycoprotein with the ability to differentiate glycosylation variations. This was
achieved through the incorporation of a boronic acid modified thymidine moiety (B-TTP,
Figure 1.15) into the DNA sequences.246 Because of the intrinsic affinity of boronic acids
for carbohydrates, the hypothesis was that the incorporation of the boronic acid moiety
would allow for the aptamer selection process to gravitate toward the “sweet spot”
(glycosylation site) and therefore allow for distinction of glycosylation variations. In
another word, this method of using boronic acid-modified DNA allows for the selection to
go after the “sweet spot.” The boronic acid moiety was functionalized with a terminal
azido group and attached to the linear linker at 5-position of thymidine triphosphate via
Cu(I)-catalyzed azido-alkyne cyclization (CuAAC) reaction.247-249 It was demonstrated
that B-TTP can be successfully recognized by DNA polymerase as substrate and
incorporated into elongating DNA sequence. Both MALDI-MS and gel electrophoresis
results support completion of full length DNA polymerization using B-TTP in place of
natural TTP in reaction. Further experiment showed that DNA polymerization and
amplification using boronic acid-labeled DNA as template was achieved with no
noticeable difference from using natural DNA template. Thus, it is not surprising that
PCR amplification of DNA using B-TTP was also attained. Among all those observed
results, it should be specifically noticed that in one particular experiment, the boronic
acid-modified DNA gel-shift band was separated from natural DNA band with the same
length and composition in the catechol-modified PAGE result. Since it is commonly
known that catechol is capable of forming tight complex with boronic acid,125-126,250-251 the
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gel-shift result serves as a good indication that the diol-binding ability of boronic acid was
well retained after being tethered to DNA backbone. Thus, all those preliminary results
are good proof-of-concept evidence supporting the feasibility of proposed idea of
developing boronic acid-based aptamers, or nucleic acid-based boronlectins (NBLs) in
the future.
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Figure 1.15 Boronic acid modified TTP (B-TTP) by Wang

1.4.4 Conclusion
In general, the biopolymer-based boronic acid sensors are created in a combinatorial
approach for either PBLs or NBLs. There have been several array methods for
evaluating PBL libraries using colorimetric detection methods, which is similar to the
lectin-microarray analysis of glycans.226-227 However, very limited number of the
individual PBL affinity toward carbohydrate analytes was reported. For the one by
Duggan, the highest PBL affinity toward carbohydrate was estimated to be around Ka of
4000 M-1, which means most of the PBLs were at Kd of about -mM level binding
affinity.230 It is understandable since none of those constructed PBLs were designed
purposely to have the structural conformation complementary to the target carbohydrate
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analytes. Thus, colorimetric array methods may be a better method to evaluate PBLs
because it’s the binding- pattern profiles that serve as the comparing parameters. In
contrast, NBLs for carbohydrate recognition are still under a developing stage. As
reported, the SELEX technique often generates aptamers of binding affinities that rival
antibodies. In one particular case, Yu and coworkers have selected out RNA aptamers
against sLex with Kd values around 10-9 to 10-11 M.242 Yet, the selected aptamers also
showed cross-reactivity issue among Lewis acid group, a similar problem resembling
lectins. This could be explained as a result from the nature of their interactions, which
were still based on hydrogen bond and hydrophobic interactions. Anslyn and coworkers
did an excellent work by combining the power of SELEX and boronic acid-carbohydrate
interaction together to address that issue.232 But in his experiment, the aptamers and
boronic acids were still separated molecules working together, and the aptamers were
only playing a tuning role in the entire binding process. In that sense, Wang lab is
working on recruiting the boronic acid moieties into the nucleic acid molecules for further
SELEX procedure.231 It was proposed that the intrinsic affinity of boronic acids toward
carbohydrates would probably lead the selecting process to bias on such interactions to
generate more selective aptamers. Thus, efforts of constructing boronic acid-modified
nucleic acid aptamers are carried out on this way.
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1.5 The objectives and contributions of this dissertation
The objective of this research is to synthesize a new fluorescent B-TTP building block
that can be enzymatically incorporated into DNA. Ideally, the boronic acid should show
fluorescent intensity increase at a visible wavelength upon glycan binding as the
reporting signal. It is critical that the property of fluorescence change for the new B-TTP
be maintained even after DNA incorporation. In this case, naphthalimide-based boronic
acid (NB) developed by our lab was chosen as the moiety to be linked to TTP, because
of its long excitation/emission wavelengths and fluorescence increasing properties.
Preliminary studies of several designed and synthesized NB-DNA were carried out to
evaluate the fluorescence changes upon model sugar binding. It was proposed that by
optimizing the DNA sequence and structure, the DNA-based boronic acid sensors with
high affinity and selectivity against specific glycan target could be obtained. The work
described in this dissertation consists of the following three key parts:
A. Synthesizing new B-TTP with intrinsic long-wavelength fluorescence
Along the line of trying to develop nucleic acid-based boronolectins, a new B-TTP
was synthesized using similar strategy as previous one.231 The advantage or
improvement of the new B-TTP is that the chosen naphthalimide-based boronic acid (NB)
fluoresces at long-wavelength and its fluorescence intensity increases upon
carbohydrate binding. It was discovered that the fluorescent properties of NB were well
retained after tethering to the 5-position of TTP, and the new B-TTP could be recognized
by DNA polymerase as a substrate.
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B. Fluorescence properties studies of NB- modified DNA sequences
After incorporation of NB-TTP into DNA sequences, fructose as model carbohydrate
was added into the DNA solution to study its fluorescence change. It was observed that
the fluorescence intensity increased in a concentration-dependent manner. Further
experiments involved several bis-boronic acid DNA sequences with different number of
bases as a spacer in between. In addition to fructose, three disaccharides were also
tested for their effects on changing NB -DNA fluorescence.
C. In vivo cell imaging study of NB-TTP
Encouraged by the in vitro enzymatic activity of NB-TTP, we were interested in seeing
the NB-TTP in vivo activities in cell cultures, which can be observed under fluorescent
microscope. In this work, it was surprising to see that NB-TTP not only was capable of
getting through cell membrane into cytoplasma, but also showed significant
accumulation in the cell nucleus. The result could be very useful for developing
fluorescent cell nucleus-labeling agents, or even mapping glycan distribution in living
cells.
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2. MATERIALS AND METHODS
.
2.1 Synthesis of napthalimide-based boronic acid modified TTP (NB-TTP)
Unless otherwise noted, starting materials and solvents were purchased from Aldrich
and Acros, and used without purification. 1H and

13

C NMR spectra were recorded on a

Bruker 400 MHz spectrophotometer in a deuterated solvent with TMS (δ = 0.00 ppm) or
NMR solvent as the internal reference unless otherwise specified.
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P NMR was

recorded using 85% H3PO4 as an external reference (in an insert). HPLC purification
was carried out with a Zobax C18 reversed-phase column (9.4 mm×25 cm).
Fluorescence spectra were recorded on a Shimadzu RF-5301 PC spectrofluorometer.
Absorption spectra were recorded on a Shimadzu UV-1700 UV/Vis spectrophotometer.
Quartz cuvettes were used in all fluorescence and UV studies. All pH values were
determined by a UB-10 Ultra basic benchtopp H meter (Denver Instruments). For all
reactions, analytical grade solvents were used. Anhydrous solvents were used for all
moisture-sensitive reactions.
4-Aminomethylbenzyl alcohol (2):
4-(Hydroxymethyl)benzonitrile (1.0 g, 7.5 mmol) dissolved in dry THF (20 ml) was
added slowly into a suspension of LiAlH4 (866 mg, 22.8 mmol) in THF(20 ml) at RT.
Foaming with bubble formation was observed while stirring. The light yellow-green
suspension was refluxed under N2 overnight. After cooling down to RT, MeOH (5 ml) was
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added to the suspension to quench the reaction. The suspension generated foams while
being stirred and cooled in an ice-bath. When no more bubble formation was observed,
NaOH (20%, 15 ml) solution was added into the suspension. The solution became
colorless while white precipitate was observed. The solution was concentrated in vaccuo
and the residue was suction-filtered. The solid was repeatedly washed with CH2Cl2. The
filtrate was combined and washed with H2O. The organic phase was separated and
concentrated on a rotavap. White solid was obtained as product (1.0 g, 98% yield). The
product underwent prolonged drying in vaccuo to remove residue solvent before the next
step reaction.
1

H-NMR (CDCl3): δ7.31 (m, 4H), 4.67(s, 2H), 3.85 (s, 2H), 1.76 (s broad, 3H)

13

C-NMR (CDCl3): δ142.7, 139.9, 127.5, 127.5, 65.2, 46.4

4-Boc-aminomethylbenzyl alcohol (3):
Into the solution of 4-aminomethylbenzyl alcohol (444 mg, 3.2 mmol) and
triethylamine (0.47 ml, 3.3 mmol) in dry THF (5 ml) was added di-t-butyl dicarbonate (750
mg, 3.4 mmol) in dry THF (3 ml) dropwise. The mixture was stirred at RT overnight and
then concentrated on a rotavap. The residue was dissolved in ethyl acetate (20 ml). The
solution was sequentially washed with NaHSO4 solution (5%, × 1), saturated NaHCO3
solution (× 1) and brine (× 1), and then dried over MgSO4. Filtration and solvent
evaporation yielded a white powder product (720 mg, 94% yield).
1

H-NMR (CDCl3): δ7.27 (m, 4H), 4.92 (s broad, 1H), 4.65 (s, 2H), 4.27 (d, 2H), 2.22 (s

broad, 1H), 1.45 (s, 9H)
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13

C-NMR (CDCl3): δ156.1, 140.3, 138.4, 127.8, 127.4, 79.7, 65.1, 44.6, 28.6

(4-Boc-aminomethylbenzyl) methansulfonate (4):
Into the solution of 4-Boc-aminomethylbenzyl alcohol (700 mg, 3.0 mmol) and
triethylamine (0.86 ml, 6.2 mmol) in dry THF (12 ml) in an ice bath, MsCl (0.38 ml, 4.9
mmol) was added dropwise. The mixture was stirred for 1 h in an ice bath. The solution
was concentrated on a rotavap and the residue was dissolved in 25 ml of ethyl acetate.
The solution was sequentially washed with NaHSO4 solution (5%, × 1), saturated
NaHCO3 solution (× 1) and brine (× 1), and then dried over MgSO4. After filtration and
solvent evaporation, a colorless oil product was obtained (896 mg, 96% yield), which
turned into white solid after prolonged drying in vacuo.
1

H-NMR (CDCl3): δ7.35 (m, 4H), 5.22 (s, 2H), 4.95 (s broad, 1H), 4.33 (d, 2H), 2.91 (s,

3H), 1.46 (s, 9H)
13

C-NMR (CDCl3): δ156.1, 140.7, 132.5, 129.4 128.0, 79.9 71.4, 44.4, 38.5, 28.6

4-Amino-N-(4’-boc-aminomethylbenzyl)naphthalimide (5):
4-Amino-naphthalimide (820 mg, 3.85 mmol) in dry DMF (20 ml) was treated with 2 M
NaOMe in MeOH (3 ml) until it became a homogenous solution with a deep red color
(took several minutes). (4-Boc-aminomethylbenzyl) methansulfonate (1.21 g, 3.85 mmol)
was then added. The solution was stirred for 3 h and then quenched by adding H2O (100
ml). The suspension was extracted with ethyl acetate (100 ml, × 2). The organic
extractions were combined and concentrated into 100 ml. The solution was washed with
H2O (25 ml, × 3) and dried over MgSO4. The removal of solvent on a rotavap gave an
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orange powder product (1.5 g, 90% yield).
1

H-NMR (D6-DMSO): δ8.63 (d, 1H, J = 7.6 Hz), 8.44 (dd, 1H, J1 = 7.2 Hz, J2 = 0.8 Hz),

8.21 (d, 1H, J = 9.2 Hz), 7.66 (t, 1H, J = 8.0 Hz,), 7.49 (s broad, 2H), 7.20 (m, 4H), 6.86
(d, 1H, J = 8.4 Hz), 5.19 (s, 2H), 4.06 (d, 2H, J = 6 Hz), 1.366 (s, 9H)
13

C-NMR (D6-DMSO): δ163.8, 162.9, 155.7, 152.9, 138.8, 136.4, 134.2, 131.2, 129.8,

129.5, 127.4, 126.9, 124.0, 121.7, 119.4, 108.2, 107.3, 77.7, 43.1, 42.2, 28.2.
MS (ESI-) : m/z (%) = 430.3 (100) [M-H]-.
Exact mass: C25H24N3O4 calc. 430.1767; found 430.1778
4-(2-Bromobenzyl)amino-N-(4’-boc-aminomethylbenzyl)naphthalimide (6):
4-Amino-N-(4’-Boc-aminomethylbenzyl)naphthalimide (5) (1.50 g, 3.49 mmol) and
sodium hydride (60% dispersed in mineral oil, 306 mg, 7.66 mmol) were mixed in dry
DMF (20 ml). The mixture was stirred for 5 min and then 2-bromobenzyl bromide (870
mg, 3.49 mmol) was added. The mixture was stirred for 3 h before quenching with water
(150 ml). The suspension was extracted with ethyl acetate (25 ml, × 3). The organic
extractions were combined and washed with water (50 ml). After separation, the organic
solvent was removed on a rotavap and the residue was purified on a silica gel column
(ethyl acetate/hexane, 1:4). A yellow powder product (840 mg, 40% yield) was obtained.
1

H-NMR (D6-DMSO): δ8.58 (d, 1H, J = 7.2 Hz), 8.43 (d, 1H, J = 8.4 Hz), 8.13 (d, 1H, J =

8.4 Hz), 7.64~7.61 (m, 2H), 7.49 (d, 2H, J = 8.0 Hz), 7.37 (dd, 1H, J1 = 7.6 Hz, J2 = 1.6
Hz), 7.30~7.28 (m, 1H), 7.27~7.18 (m, 2H), 6.68 (d, 1H, J = 8.4 Hz), 5.78 (s, 1H), 5.33 (s,
2H), 4.75 (s, 1H), 4.69 (d, 2H, J = 5.6 Hz), 4.24 (d, 2H, J = 5.6 Hz), 1.43 (s, 9H)
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13

C-NMR (D6-DMSO): δ164.8, 164.2, 156.0, 149.1, 138.0, 137.2, 136.1, 134.7, 133.5,

131.6, 130.0, 129.8, 129.5, 129.3, 128.1, 127.8, 126.2, 125.2, 123.8, 123.4, 120.6, 111.3,
105.3, 79.6, 48.3, 44.7, 43.2, 28.6
MS (ESI+): m/z (%) = 600.5 (100) [M+H]+.
Exact mass: C32H31BrN3O4 calc. 600.1498; found 600.1504
4-(2-Dihydroxylboryl-benzyl)amino-N-(4’-boc-aminomethylbenzyl)naphthalimide
(7):
4-(2-Bromobenzyl)amino-N-(4’-boc-aminomethylbenzyl)naphthalimide (6) (391 mg,
0.65 mmol), PdCl2(dppf) (160 mg, 0.20 mmol), bis(neopentyl glycolato)diboron (368 mg,
1.63 mmol) and KOAc (198 mg, 2.02 mmol) were mixed in a dry flask under N2.
Anhydrous DMSO (5 ml) was injected into the mixture. The solution was heated at
80~85 ℃ under N2 for 5 h. Then the solution was cooled down to RT. Water (25 ml) was
then added to quench the reaction. The solution was extracted with ethyl acetate (25ml,
× 2). The extractions were combined, washed with water (25ml, × 2) and concentrated
on a rotavap. The residue was purified on a silica gel column, and the crude product was
eluted out by ethyl acetate/MeOH = 10:1. The crude product was further purified on two
20 × 20 cm preparatory TLC plates (ethyl acetate/MeOH = 5:1). The orange fluorescent
band (Rf = 0.1~0.5) was cut out and extracted with MeOH. Orange color solid product
was obtained (167 mg, 45% yield).
1

H-NMR (MeOD): δ8.22 (d, 1H, J = 8.0 Hz), 8.04 (d, 1H, J = 8.8 Hz), 7.58 (d, 1H, J = 7.2

Hz), 7.42 (d, 2H, J = 7.6 Hz), 7.33~7.25 (m, 4H), 7.19~7.16 (m, 3H), 6.17 (d, 1H, J = 8.4
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Hz), 5.30 (s, 2H), 4.55 (s, 2H), 4.15 (s, 2H), 1.42 (s, 9H)
13

C-NMR (MeOD): δ167.8, 166.2, 164.7, 158.7, 141.6, 139.5, 138.9, 133.6, 130.9,

129.4, 129.1, 129.0, 128.8, 128.3, 127.5, 126.4, 119.6, 104.0, 101.8, 80.3, 47.7, 45.0,
43.8, 30.9, 28.9
MS (ESI-) : m/z (%) = 564.3 (100) [M-H]-.
Exact mass: C32H31BN3O6 calc. 564.2306; found 564.2310
4-(2-Dihydroxylboryl-benzyl)amino-N-(4’-aminomethylbenzyl) naphthalimide (8):
4-(2-Dihydroxylboryl-benzyl)amino-N-(4’-Boc-aminomethylbenzyl)naphthalimide

(7)

(390 mg, 0.69 mmol) was suspended in CH2Cl2 (12 ml) and TFA (1.2 ml, 15.6 mmol) was
added in one-shot. The mixture was stirred at RT for 0.5 h and then concentrated on a
rotavap. The residue was washed with a saturated K2CO3 solution. Then the residue was
dissolved in methanol and loaded on two 20 × 20 cm preparatory TLC plates. 100% ethyl
acetate was used to develop first. Later, ethyl acetate/MeOH (5:1) was used to develop
the plate. The orange fluorescent band (Rf = 0.2~0.3) was cut out and extracted with
MeOH. An orange color solid product was obtained (210 mg, 66% yield).
1

H-NMR (MeOD): δ8.21 (d, 1H, J = 6.8 Hz), 8.03 (t, 1H, J = 4 Hz), 7.58 (d, 1H, J = 7.2

Hz), 7.44~7.37 (m, 4H), 7.29~7.25 (m, 4H), 7.17 (t, 1H, J = 7.2 Hz), 6.16 (d, 1H, J = 8.8
Hz), 5.32 (s, 2H), 4.55 (s, 2H), 3.86 (s, 2H),
13

C-NMR (MeOD): δ167.8, 166.1, 141.6, 140.2, 138.8, 133.6, 130.9, 129.4, 129.3,

129.2, 128.9, 127.5, 126.3, 119.4, 103.8, 101.8, 47.9, 45.5, 43.8
MS (ESI-): m/z (%) = 492.3 (100) [M-H-2H2O+2MeOH]-, 478.3 (70) [M-H-H2O+MeOH]-,
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464.3 (50) [M-H]-.
Exact mass: C27H23BN3O4 calc. 464.1782; found 464.1796
4-(2-Dihydroxylboryl-benzyl)amino-N-(4’-azidoacetyl-aminomethylbenzyl)naphthalimide (9):
4-(2-Dihydroxylboryl-benzyl)amino-N-(4’-aminomethylbenzyl)naphthalimide (8) (210
mg, 0.45 mmol), EDCI (170 mg, 0.90 mmol), and azidoacetic acid (91 mg, 0.90 mmol)
were mixed in anhydrous DMF (10 ml). The mixture was stirred at RT under N2 for 1 h.
The solution was concentrated by oil pump at 35 °C. The residue was rinsed with H2O
and then saturated K2CO3 solution. After that, the residue dissolved in ethanol was
loaded on to two 20 × 20 cm preparatory TLC plates and 100% ethyl acetate was used to
develop first. Later, ethyl acetate/MeOH (10:1) was used to develop the plate.

The

orange fluorescent band (Rf = 0.2~0.3) was cut out and extracted with MeOH. An orange
color solid product was obtained (241 mg, 98% yield).
1

H-NMR (MeOD): δ8.23 (d, 1H, J = 7.2 Hz), 8.06 (d, 1H, J = 8.4 Hz), 7.59 (d, 1H, J = 6.8

Hz), 7.42 (d, 2H, J = 7.6 Hz), 7.33 (d, 2H, J = 8.0 Hz), 7.27 (t, 2H, J = 7.6 Hz), 7.21~7.17
(m, 3H), 6.19 (d, 1H, J = 8.8 Hz), 5.30 (s, 2H), 4.55 (s, 2H), 4.34 (s, 2H), 3.88 (s, 2H)
13

C-NMR (MeOD): δ170.1, 167.8, 164.6, 141.5, 139.3, 138.9, 138.2, 133.6, 130.9, 129.4,

129.2, 128.9, 128.8, 127.6, 126.5, 119.8, 104.3, 101.8, 53.1, 47.5, 44.2, 44.0, 43.8, 30.9,
18.5
MS (ESI-): m/z (%) = 547.3 (100) [M-H]-, 561.3 (50) [M-H-H2O+MeOH]-.
Exact mass: C29H24BN6O5 calc. 464.1782; found 464.1796
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The M-TTP was synthesized following previously published procedure (Scheme
3.2).231
5-[3-(Trifluoroacetamido)-propynyl]-2’-deoxyuridine (10):
5-Iodo-2’-deoxy uridine (354 mg, 1.0mmol) was dissolved in degassed dry DMF (10
mL). Copper (I) iodide (38 mg, 0.2 mmol), freshly distilled triethylamine (0.28 mL, 2.0
mmol) and freshly distilled N-propynyltrifluoroacetamide (453 mg, 3.0 mmol) were added
later. The mixture was stirred for 30min in dark under N2 protection until everything
dissolved. Tetrakis(triphenylphosphine) palladium (0) (116 mg, 0.10 mmol) was added
and the mixture was stirred overnight in dark under N2 protection at r.t.. Then solvent was
removed and the residue was purified with a silica gel column (dichloromethylene:
methanol=15:1) to give white solid product (320 mg, 85%)
1

H-NMR (DMSO): δ 2.12 (2H, m), 3.59 (2H, m), 3.79 (1H, d), 4.23 (3H, d), 5.09 (1H, t),

5.25 (1H, d), 6.10 (1H, t), 8.19 (1H, s), 10.07 (1H, s)
5-[3-Amino-propynyl]-2’-deoxyuridine (11)
Compound 10 (250 mg, 0.64 mmol) was dissolved in ammonium hydroxide (5 ml)
and stirred overnight. The solution was concentrated in vacuo and residual water was
removed by oil pump for 24h to give product as deep yellow oil (180 mg, 100%)
1

H-NMR (DMSO): δ 2.14 (2H, m), 3.59 (3H, m), 3.82 (1H, m), 3.92 (2H, s), 4.24 (1H, m),

5.20 (2H, br), 6.10 (1H, t), 8.25 (1H, s)
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5-[3-(4-Pentynoic amido)-propynyl]-2’-deoxyuridine (12)
Compound 11 (180 mg, 0.64 mol) was dissolved in dry DMF (5 ml). 4-Pentynoic acid
(68mg, 0.69mmol) and PyBop (515 mg, 0.99 mmol) were added into the solution under
ice bath cooling. The mixture was stirred overnight at r.t.. The solvent was removed at
78 °C in vacuo and the residue was purified with silica gel chromatography
(dichloromethylene: methanol=15:1) to give pure product as white solid (89 mg, 37%):
1

H-NMR (DMSO): δ 2.11 (2H, dd), 2.28-2.39 (4H, m), 3.53-3.63 (2H, m), 3.79 (1H, quart),

4.10 (2H, d), 4.22 (1H, m), 5.10 (1H, t), 5.25 (1H, d), 6.11 (1H, t), 8.17 (1H, s), 8.43 (1H,
t)
M-TTP:
All liquid reagents and solvents were freshly distilled to be anhydrous. Compound 12
(0.15 g, 0.4 mmol) and proton sponge (0.102 g, 0.48 mmol) were dried in vacuo over
P2O5 overnight and then dissolved in anhydrous trimethylphosphate (0.6 ml) under
nitrogen. Then the mixture was cooled in an ice bath and POCl3 (44 μL, 0.5 mmol) was
added dropwise via a syringe with stirring. The reaction mixture was stirred on ice for 2 h
and then bis-tri-n-butylammonium pyrophosphate (0.98 g) dissolved in DMF (1.6 ml) and
tri-n-butylamine (0.6 ml) was added in one portion. The mixture was stirred at room
temperature for 10 min and then triethylammonium bicarbonate solution (0.1 M, pH8, 10
ml) was added. The reaction mixture was stirred at room temperature for an additional
hour and concentrated on a rotavap equipped with an oil pump. The residue was purified
with a DEAE-Sephadex A-25 column using a linear gradient concentration (0-0.6 M) of
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NH4HCO3 aqueous buffer solution. Monitored with the UV 260nm absorbance, the
product was eluted out by 0.12–0.15 M NH4HCO3 fraction. The elution was collected and
lyophilized to give the final product as a white powder (161 mg, 60%).
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1

P-NMR (D2O, internal standard: 85% H3PO4): δ -5.34(γ P), -10.14(α P), -18.60(β P)

H-NMR (D2O): δ 7.99 (s, 1H), 6.30 (t, 1H), 4.58 (m, 1H), 4.21 (m, 5H), 2.51 (m, 4H),

2.37 (m, 3H)
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Scheme 2.1 Synthesis route of M-TTP

NB-TTP:
4-(2-dihydroxylboryl-benzyl)amino-N-(4’-azidoacetyl-aminomethylbenzyl)naphthalimi
de (7) (10 mg, 0.018 mmol) and M-TTP (10 mg, 0.017 mmol) were mixed in a flask under
N2. MeOH/H2O (1:1, 200 μl) was injected into the flask later to suspend the mixture with

63

stirring. TBTA (1.7 mg, 0.0033 mmol) and CuBr solution (0.24 mg, 0.0017 mmol) in 50 μl
DMF were added later. The reaction mixture was sonicated for several minutes and then
stirred at RT under N2 for 5 h. The reaction was quenched by adding 1 ml of H2O and
then centrifuged at 13.5k rpm for 15 min. The aqueous supernatant was collected and
the residue was repeatedly extracted with 100 mM NH4HCO3 buffer pH 8.0 until the
extraction was no longer deep orange. The aqueous extractions were combined and
purified by HPLC. The collected fraction was lyophilized into orange color powder. The
product was washed with MeOH and ice-cold water to remove residual starting material.
Further purification of NB-TTP was achieved by MeOH precipitation of the saturated
aqueous solution. A bright red-orange colored powder was obtained as pure product (5
mg, 25% yield)
11

B-NMR (D2O, internal standard: 15% BF3 in ether): δ29.9
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1

P-NMR (D2O, internal standard: 85% H3PO4): δ-5.41 (γ P), -10.31(α P), -18.60(β P)

H-NMR (D2O/MeOD = 2:1, Watergate solvent suppression): δ8.17 (d, 1H, J = 7.6 Hz),

7.91 (d, 1H, J = 9.2 Hz), 7.7~7.5 (m, 2H), 7.1~7.5 (m, 9H), 6.07 (d, 1H, J = 9.2 Hz), 5.95
(t, 1H), 5.25 (s, 1H), 4.3~4.0 (m, 3H), 2.94 (t, 2H) , 2.47 (t, 2H), 2.16 (t, 2H)
MS (ESI-): m/z 1032.3 (100) [M-H-2H2O-HPO3]-, 1112.3 (20) [M-H-2H2O]-, 1134.3
[M-H-3H2O+MeOH]- , 1054.3 [M-H-3H2O+MeOH-HPO3]MS

(MALDI

linear

mode):

m/z

1112.57

(100)

[M-H-2H2O]-,

1032.97

[M-H-2H2O-HPO3]Exact mass: [M-H-2H2O]- C46H42BN9O18P3 calc. 1112.1954; found 1112.1940.

(45)
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2.2 Photo stability test of boronic acid 9:
Solution of boronic acid 9 (1×10–6 M) in 0.1 M phosphate buffer at pH 7.4 was
prepared. Using the Time Course function of Shimadzu RF-5301 PC spectrofluorometer,
excitation wavelength was fixed at 490 nm. Both excitation and emission slits were set at
5 nm. The fluorescence intensity measurements were taken every 0.3 s at two
wavelengths (540 and 570 nm) and the fluorescence was monitored for 3600 s [Figure
2.1 (a)]. The entire fluorescence spectrum was scanned at the end point [Figure 2.1 (b)]
It can be seen that the fluorescence intensity was constant at both tested emission
wavelength (540 and 570 nm) and the fluorescence profiles overlap very well after
constant irradiation for 1 h and 2 h.

(a)

(b)

Figure 2.1 Photostablity studies of boronic acid 9 in 0.1 M phosphate buffer at pH 7.4
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2.3 Mass spectrometry
ESI-MS work was performed using a Waters Micromass Q-TOF micro instrument.
Data were acquired in either a positive and negative ion mode by syringe pump infusion
of the sample solutions at a flow rate of 7 µL/min. The MALDI mass spectrometry
analysis was performed on an Applied Biosystems 4800 plus MALDI TOF/TOF analyzer
mass spectrometer (Framingham, MA). This instrument is equipped with a
Diode-pumped Nd:YAG laser at 355-nm. The mass spectra were acquired as an
average of 3 shots with the same laser intensity attenuator setting (4002 arbitrary unit)
for all samples. All spectra were recorded on a biomass spectrometer in
linear-negativemode

with

delayed

extraction.

3-Hydroxypicolinic

acid

(3-HPA)/diammonium citrate (9:1) in water was used as the matrix. A 10:1 matrix:sample
mixture was prepared, applied to the sample plate as 1 μL drops, and allowed to air dry
before analysis. 25 kV acceleration voltage was used. A mass range of 1000–10000 was
scanned. Each spectrum was summed frommultiple spectra at different spots. Proteins,
such as insulin, thioredoxin, and apomyoglobin, were used as external standards. This
work was performed by at the Mass Spectrometry Facilities of Georgia State University.
2.4 High Performance Liquid Chromatography (HPLC) for NB-TTP purification
The aqueous extractions of crude NB-TTP product with 100 mM NH4HCO3 buffer pH
8.0 were combined and purified by HPLC (Zobax C18 RP preparatory column, Shimadzu
LC-10AT VP system). Elution condition: 100 mM NH4HCO3 buffer pH 8.0 /CH3CN (3
ml/min), 0–10 min (CH3CN 10%), 10–30 min (CH3CN, 10-100%), 30–40 min (CH3CN,
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100%), 40–45 min (CH3CN, 100-10%), 45–55 min (CH3CN, 10%). Rt = 17.5-22.5 min.
The collected fraction was lyophilized into orange color powder. The product was
washed with MeOH to remove residual starting material and extracted again with 100
mM NH4HCO3 buffer. The extraction was lyophilized again to give the pure product.
2.5 NB-TTP Fluorescence binding tests
Solutions of NB-TTP (1×10–6 M) and NB-TTP (1×10–6 M) with D-fructose (0.1 M) were
prepared in 0.1 M phosphate buffer at pH 7.4, respectively. These two solutions were
mixed in various ratios to give the desired D-fructose concentrations (10-3 to 0.1 M). 3 ml
of each mixed solution was used to test the fluorescence intensity several minutes after
mixing. Eight points were collected for the calculation of the apparent binding constant Ka
assuming a 1:1 complex formation mechanism. These studies were run in triplicate.
The binding constants were determined using the following equation:
I0/(I-I0)=(εB/εB-SKa)*1/[fructose]+ εB/εB-S
where I0 is fluorescence intensity of NB-TTP solution; I is NB-TTP fluorescence intensity
upon adding sugar, εB is fluorescence correlation factor of NB-TTP; εB-s is the
fluorescence correlation factor of NB-TTP-fructose complex; Ka is the binding constant;
[fructose] is the sugar concentration.
2.6 Primer extension using the Klenow fragment for MALDI-TOF-MS studies
14-nt Primer (16 μM), 21-nt template (6.8 μM), Klenow (0.1 units/μl), TTP (0.3 mM) or
NB-TTP (0.3 mM), and three other dNTPs (0.3 mM each) in total volume of 100 μl were
incubated at 37 °C for an hour. The prepared DNA was purified using Microcon YM-3
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centrifugal filter (Millipore Corp.) to remove dNTPs and other low molecular weight
molecules. The harvested DNA was further purified by 5 M NH4OAc/ethanol precipitation
(three times) as a way to replace metal ions with ammonium as the phosphate
counterions.252 The DNA pellet was dissolved in 10 μl for MALDI-TOF-MS analysis. The
oxidative deborylated NB-DNA sample was prepared by adding 0.25 μl of H2O2 solution
(100 mM) into 5 μl of NB- DNA solution. MALDI mass spectral results were obtained
using insulin as the internal standard.
2.7 PAGE analysis of primer extension
A mixture of 14-nt primer DNA (50 μM), T4 polynucleotide kinase (0.5 units/μl,
Biolabs, Inc.) and γ-32P-ATP (0.6 μl, from Perkin-Elmer Corp.) in 12 μl T4 kinase buffer
solution was incubated at 37 °C for 1 h. The

32

P-labeled DNA was purified using

Microcon YM-3 centrifugal filter (Millipore Corp.) to remove low molecular weight
molecules. Using a similar primer extension protocol as previously described, the
32

P-labeled primer alone, reaction mixture without enzyme, reaction mixture without

dNTPs, reaction mixture with both enzyme and natural dNTPs and reaction mixture with
NB-TTP, the other 3 dNTPs and enzyme were incubated at 37 °C for 1 h. The reactions
were quenched with 2× DNA loading dye. 3 ul of samples from each reaction were taken
and run on 15% PAGE at 300V for 3 h. Later, the gel was fixed and dried. Film was
developed after autoradiography with the dried gel for overnight.
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2.8 NB -DNA fluorescence binding tests
2.8.1 Double stranded NB- DNA binding tests
Primer (7 μM), Template 0~7 (7 μM), Klenow (0.1 units/μl), NB-TTP (125 μM), and
three other dNTPs (0.3 mM each) in total volume of 200 μl were incubated at 37 °C for
an hour. After purification of the DNA through membrane filtration and NH4OAc/ethanol
precipitation three times, the orange-colored DNA pellet was supposed to be
quantitatively precipitated out,252 and dissolved in 50 μl of H2O. 45 μl of the NB- dsDNA
solution was diluted by 4.5 ml 0.1 M phosphate buffer (pH 7.4) to make theoretical
concentration of 0.5 μM solution. D-fructose was added into the DNA solution with
concentration increasing from 10-3 to 0.1 M. 1 ml of solution was used to test the
fluorescence intensity more than 5 minutes after mixing. Each test was triplicated.
2.8.2 Single stranded NB- DNA binding tests
Primer (21 μM), Template 0~7 (7 μM), Klenow (0.1 units/μl), NB-TTP (125 μM), and
three other dNTPs (0.3 mM each) in total volume of 200 μl were incubated at 37 °C for
an hour. After purification of the DNA through membrane filtration and NH4OAc/ethanol
precipitation three times, the orange-color DNA pellet was dissolved in 50 μl of H2O. 45
μl of the NB- ssDNA solution was heated at 90 oC for 1 min, then quickly cooled down in
ice bath and diluted by 2.5 ml 0.1 M phosphate buffer (pH 7.4) to make theoretical
concentration of 0.56 μM solution. 0.5 ml of each NB- ssDNA solution was mixed with 0.5
ml of phosphate buffer (blank), 0.5 ml of D-fructose phosphate buffer solution (0.2 M),
0.5 ml of D-lactose phosphate buffer solution (0.2 M), 0.5 ml of D-maltose phosphate

69

buffer solution (0.2 M), and 0.5 ml of D-sucrose phosphate buffer solution (0.2 M)
solution respectively. 1 ml of each NB-ssDNA/sugar solution was tested the fluorescence
intensity more than 5 minutes after mixing. The fluorescence intensity was divided by
that of the blank to calculate the increasing fold. Each test was triplicated.
2.9 HeLa cell sub-culture and fluorescence imaging study
2.9.1 HeLa cells sub-culture
The cells have to be sub-cultured or passaged as part of maintenance to prevent over
growth of the cells. The process is common for any adherent cell line.253 A sterile flask
was taken, added with 19.5 ml of fresh medium (DMEM + 10% Normal FBS + 1%
Penicillin/Streptomycin) and incubated in a CO2 incubator at 37 oC, 5% CO2 and 90%
relative humidity.
T-75 flask with 80-85% confluent culture was taken out from the CO2 incubator and
the spent medium was removed. The cells were washed for 2 min with10ml of DPBS
twice. 2-3 ml of trypsin (0.25%, from Mediatech, Inc) was add to the flask and incubated
for 2 min in a CO2 incubator at 37oC, 5% CO2 and 90% relative humidity. After 2-3 mins,
the flask was removed from the incubator and 4ml of fresh medium was added to
neutralize the effect of trypsin. The suspension was mixed gently to break the clumps.
0.5ml of the suspension was drawn and added into the flask with pre-warmed fresh
medium. The flask was kept for incubation in a CO2 incubator at 37 oC, 5% CO2 and 90%
relative humidity.
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2.9.2 HeLa cells fluorescence imaging study
A T-75 flask of 80% confluent HeLa cell line was treated with 3 ml of trypsin (0.25%,
from Mediatech, Inc). Cover slips were sterilized by treatment with 70% ethanol and then
exposed to UV light in the laminar airflow. The sterilized cover slips were carefully placed
into the 24-well plate and 500uL of cell suspension was added onto the cover slip in each
well. The plate was left in the incubator at 37 oC, 5% CO2 and 86% humidity until the cell
line reached 50-60% confluence (approximately 24hr).
After incubation, test fluorescence compound dissolved in growth medium was added
to the cells in the 24-well plate at required concentrations. The plate was left in the
incubator at 37 oC, 5% CO2 and 86% humidity. After incubation for 24 hr, medium from
each well was removed and the cells were gently washed with 500 ul PBS twice. 200 ul
of ice-cold methanol was added to each well and incubated at r.t. for 5 mins. Then
methanol was removed and the cells were washed again with 500 ul PBS twice.
The cover slips were carefully removed from the wells using a forceps and placed an
inverted position on slides with the cells side facing the slide. The coverslips were dried
with Kimwipes and the edges were sealed using clear nail polish. The slides with
coverslips on top were inverted and observed under a Zeiss Axiovert 400M inverted
epifluorescence microscope using the 40X oil lens with Immersol 518F oil. The filter
cubes were switched to FITC (495/520) channel and the images were captured using
AxioVision Rel 4.6 program.
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2.9.3 HeLa cells crude protein and genomic DNA extraction:
The procedures were following the technical manual of Wizard genomic DNA
purification kit by Promega Corporation. The cultured cells were first trypsinized and
transferred to a 1.5ml microcentrifuge tube. The cells were pelleted by centrifuging at
13,000 × g for 10 sec. The supernatant was removed. The pellet was washed with 200 μ
L PBS and centrifuged again. The pellet was added with 600 μL of Nucleic Lysis
Solution and pipette until no visible cell clumps remain. 3 μL of RNase Solution was
added into the lysate solution and mixed by inverting the tube 2-5 times. The mixture was
incubated at 37 ° C for 30 min and then cooled down to r.t. 200 μ L of Protein
Precipitation Solution was added into the mixture and the mixture was vortexed
vigorously for 20 sec. The sample was chilled on ice for 5 min. The protein was
precipitated by centrifuging at 13,000 × g for 4 min. The tight white pellet was collected at
crude protein extraction. It was dissolved in 1 mL of PBS and directly subjected for
fluorescence test.
The supernatant was transferred to a clean 1.5 mL microcentrifuge tube containing
600 μL of isopropanol. The solution was gently inverted until white thread-like strands of
DNA form a visible mass. The suspension was centrifuged at 13,000 × g for 1 min and
the supernatant was removed. The DNA white pellet was added with 600 μL of 70%
ethanol. The mixture was gently inverted several times to wash the DNA and then
centrifuged at 13,000 × g for 1 min. The supernatant was removed and the pellet was
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air-dried for 15 min. The DNA was rehydrated by incubating with 100 μL of DNA
Rehydration Solution at 65 °C for 60 min. The solution was diluted by PBS into 1 mL
solution and subjected for fluorescence test.
2.9.4 Isolation of HeLa cell nuclei
The procedure was following the method described by Gonzalez-Lazaro.254 The
cultured HeLa cells were trypsinized and washed with PBS. The cell pellet was
suspended in 1 mL of solution 1 (0.32 M sucrose, 0.002 M MgCl2, 0.001 M K2HPO4, pH
6.8) and centrifuged at 1000 × g for 7 min. The supernatant was removed and the pellet
was resuspended in 1 mL of solution 2 (0.01 M NaCl, 0.001 M K2HPO4, pH 6.8) and
incubated at 4 °C for 15 min. The cells were then centrifuged at 800 × g for 10 min. The
supernatant was removed and the pellet was suspended in 1 mL of solution 3 (0.32 M
sucrose, 0.001 M MgCl2, 0.3% Triton X-100, 0.001 M K2HPO4, pH 6.2-6.4). The cells
were lysed through a 22-gauge needle (10 passes). The partially lysed cells were then
centrifuged at 800 × g for 10 min and the supernatant was discarded. The pellet was
suspended in 1 mL of solution 3 and lysed through a 22-gauge needle (10 passes) again.
The lysed cells were centrifuged and the pellet was washed with solution 1. All
instrument and solutions were pre-cooled at 4 °C before usage and the experiment was
carried out at r.t. as quick as possible.
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3. SYNTHESIS AND ENZYMATIC STUDIES OF NAPHTLIMIDE-BASED BORONIC
ACID-CONJUGATED TTP (NB-TTP)
3.1 Introduction
Our lab has had a long-standing interest in using the boronic acid moiety, which is
known

to

interact

with

diols/carbohydrates,

fluoride,

cyanide,

and

other

nucleophiles/Lewis bases,122,200 as a recognition group for sensing and other
applications.123 Recently, we have reported the synthesis of a boronic acid-modified
thymidine triphosphate (B-TTP),231 its enzymatic incorporation into DNA, and discussed
the feasibility of using it in DNA aptamer selection. Along this line, we desire to
incorporate a fluorescent boronic acid into DNA that has the following properties: (1) the
excitation and emission wavelengths are longer than the λmax of nucleobases; (2) shows
fluorescent property changes upon carbohydrate binding; (3) is stable under PCR
conditions; (4) is stable under copper-mediated “click” conditions with DNA;255-256 and (5)
is relatively easy to synthesize.
To synthesize another B-TTP with improved features such as intrinsic fluorescence
emission at long-wavelength, 4-amino-1,4-naphthalimide (Nap) was chosen as the
fluorophore after careful consideration and evaluation. Before, Heagy and coworkers
reported a series of 1,4-naphthalimide based N-phenylboronic acids.177 They were
promising in the sense of their long wavelength emission (550 nm) and good water
solubility, but were limited in applications because their fluorescence decreases upon

74

sugar binding. Mohr and coworkers developed one 1,4-naphthalimide based
carbohydrate sensor with a terminal boronic acid at the 4-amino position linked through
an aliphatic chain.257 The designed 1, 5-relationship of the boronic acid with the nitrogen
at the aliphatic linker was proposed to interact through B-N bond formation to modulate
the PET (photoinduced electron transfer) system that influence the fluorescence
properties.139 An alternative hydrolysis mechanism was also proposed to explain the
same phenomenon by the Wang group.172 The Mohr boronic acid sensor showed a
maximum of 130% fluorescence intensity increase upon D-fructose addition (λex: 410 nm,
λem:

530

nm,

pH

7.15).

Recently,

a

systematic

study

of

novel

4-amino-1,4-naphthalimide-derived phenylboronic acids was carried out by our group. A
comprehensive mechanistic investigation of the fluorescence changing was also
performed.170,258 In this case, boronic acid was directly functionalized in 1,5-relationship
with the nitrogen of the 4-aniline group (Figure 3.1). Sensor 1a showed 2.5-fold and
1.1-fold fluorescence intensity increase upon fructose and glucose binding, respectively
(λex: 493 nm, λem: 570 nm, 0.1% MeOH in 0.1M phosphate buffer, pH 7.4).258
Interestingly, sensors 1b-1c with modification at the para- position by different
electron-withdrawing or electron-donating groups didn’t result in much changes in
carbohydrate binding constants and fluorescence intensity increases. However,
correlation of the boronic acid pKa values and binding indicated a general Hammett
correlation trend with different substituents.170 It was proposed that an excited-state
internal charge-transfer (ICT) mechanism was responsible for the fluorescence intensity
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increase accompanying decreased solvent polarity, increased pH value or upon
carbohydrate binding. It was suggested that through stabilization of the excited-state
charge separation by the negatively charged boronate, bathochromic shift of the UV λmax
value with increased absorption intensity could at least partially contribute to the
increased fluorescence emission intensity. In addition, the carbohydrate-boronate ester
formation would limit the rotation around C-N bond due to steric hinderance, which could
lead to a higher fluorescence quantum yield and thus enhanced fluorescence intensity.
Also, the boronate ester formation could increase the B-N distance, which would lessen
the stabilization effect of boronate on the excited-state charge–transfer species, and
caused the hypsochromic shift of both the UV λmax value and fluorescence emission
wavelength upon carbohydrate addition. The increased B-N distances upon
carbohydrate binding were supported by molecular modeling calculations using density
function theory (DFT) in a polarizable continuum model (PCM).

O

N

HN
1a X = H
1b X = OMe
1c = COOMe
1d = F
X

O

OH
B
OH

Figure 3.1 4-Amino-1,4-naphthalimide-derived phenylboronic acids by Wang
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Through tethering the boronic acid sensor 1a to the 5-position of TTP, it is expected
that the fluorescent TTP analogue could yield DNA aptamers with not only high affinity
and selectivity against carbohydrate analytes, but also fluorescence changes in the
visible range as reporting signals.
3.2

Results and discussion

3.2.1 Synthesis of NB-TTP
The NB-TTP design strategy (Figure 3.2) was similar as the previous one,231 by
choosing 4-amino-1,4-naphthlimide (Nap) as the fluorphore, benzyl boronic acid as the
carbohydrate-binding moiety, and a terminal alkyne at TTP 5-position (M-TTP, Figure
1.15) for linkage. The final coupling step was designed through Cu(I)-catalyzed
alkyne-azide cyclization (CuAAC),247,249,259 which is a commonly used and efficient way
of linking a large fluorophore group to biomolecules.
O
triazole linkage
O
N
H
O

N

N
N

N
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O
O
HO P O P O P O
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OH

O

O

N
H

NH
N

O

O
OH

naphthalimide fluorophore
HN

OH
B
OH

boronic acid for diol binding
5-modified TTP

Figure 3.2 NB-TTP design strategy
The naphthlimide-based boronic acid (NB) 9 was synthesized in eight consecutive
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steps starting from reduction of 4-(hydroxymethyl)benzonitrile with LiAlH4, followed by
Boc- protection of the -NH2 group and methansulfonation of the –OH group to give 4.
Alkylation of 4-amino-naphthalimide with 4 and 2-bromobenzyl bromide sequentially
yields the aromatic bromide 6(aNap), which was subjected to Pd(II) catalyzed borylation
in the subsequent step. The obtained boronic acid 7 (NB7) was deprotected of the Bocgroup using TFA and then coupled with azidoacetic acid through EDCI to give boronic
acid 9 with a terminal azide linker (Scheme 3.1).
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i) LiAlH4, THF reflux, 98%; ii) di-t-butyl dicarbonate, Et3N, THF, 94%; iii) MsCl, Et3N, THF, 96%; iv) NaOMe,
4-amino-naphthalimide, DMF, 90%; v)NaH, 2-bromo-benzyl bromide, DMF, 40%; vi) Bis(neopentyl glycolato)
diboron, PdCl2(dppf), KOAc, DMSO, 45%; vii) TFA, CH2 Cl2, 66%; viii) azidoacetic acid, EDCI, DMF, 98%

Scheme 3.1 Synthesis route of naphthalimide-based boronic acid (NB)9

N3
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During the experiment, it was observed in Step vii and viii that low yields were
achieved with large amount of insoluble solid. Normally, both Boc- deprotection by TFA
and EDCI coupled amide formation should give close to quantitative yield. Later
treatment of the solid with saturated K2CO3 solution made it soluble in MeOH. It was
revealed by 1H-NMR their identity as the boronic acids 8 and 9, respectively. Thus, the
solubility of 4-amino derived phenylboronic acids of naphthlimide was greatly affected by
pH. Acidic condition created by TFA or azidoacetic acid could significantly decrease the
boronic acid solubility.
Before coupling boronic acid 9 with M-TTP, we performed a photostability test of it
because photo bleaching is a common problem faced by many fluorophores.260-261

It

can be seen that the fluorescence intensity was constant at both tested emission
wavelength (540 and 570 nm) and the fluorescence profiles overlap very well after
constant irradiation for 1 h and 2 h (Figure 2.1). Thus, photo stability should not be a
major issue in this case, which further improves the chance of success for this type of
boronic acid.
In the coupling step, TBTA (tris-(benzyltriazolylmethyl)amine) was added as a Cu(I)
ligand to accelerate the reaction rate and also protect the product from metal-catalyzed
degradation (Scheme 3.2).255,262-264 Due to the poor solubility of boronic acid under acidic
condition, extraction of NB-TTP from reaction mixture was achieved using basic 0.1M
NH4HCO3 buffer (pH 8.0). After HPLC purification of the buffer extraction, the lyophilized
NB-TTP product was washed with MeOH and ice-cold water to remove the residual
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amount of starting material 9. Characterization of NB-TTP with 1H-NMR in pure D2O was
not successful due to the continuous peaks in aromatic region (δ: 7-9 ppm) which were
indistinct. The reason was assumed to be due to the naphthlimide aromatic stacking
(π-π stacking) in aqueous environment. High quality of 1H-NMR spectrum data were
obtained by dissolving NB-TTP in a mixed solvent of D2O/MeOD (2:1) with Watergate
solvent suppression method. Surprisingly, NB-TTP had very low solubility in water
despite of its highly hydrophilic triphosphate moiety. Using UV absorbance method, it
was determined that the NB-TTP saturated aqueous solution had a concentration of
lower than 170 μM. This is also good evidence to support the theory of naphthlimide
stacking in aqueous solution. However, it was also observed that in the presence of
MeOH the water solubility of NB-TTP was further decreased. In fact, dissolving NB-TTP
in water followed by MeOH precipitation served as an excellent way for its purification.
Thus, NB-TTP behaved as an amphiphilic molecule with one end of hydrophobic
fluorophore and the other end of hydrophilic nucleoside triphosphate. In practice,
vigorous shaking of the NB-TTP aqueous solution resulted in foaming similar to soaps or
other detergent solutions. The identity of NB-TTP was also confirmed with mass
spectrometry. With a calculated [M-H]-1 of 1149.65, m/z: 1112.2 was obtained as the
major peak in negative mode of ESI-MS, which corresponded to the fragment ion of
[M-H-2H2O]-. While it is normal for boronic acid or nucleoside triphosphate to lose one
molecule of H2O in mass spectrum, it is not surprising to see two molecules of H2O were
lost in a boronic acid- nucleoside triphosphate conjugate molecule.
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Scheme 3.2 Synthesis of NB-TTP using CuAAC

Since the newly designed NB-TTP was featured with its unique fluorescence
properties change upon carbohydrate binding, fructose was chosen as the model
molecule for validation test before its incorporation into DNA sequences. Hence, as
shown in Figure 3.3 (a), the fluorescence intensity of NB-TTP increased upon D-fructose
addition in a concentration dependent fashion (λex: 490 nm, λem: 540 nm). Thus, the
binding constant Ka was calculated using the equation described in Section 2.5 in
Chapter 2.265 The Ka was determined to be 73 ± 5 M-1 from triplicate experiments. Such
results demonstrate that even after conjugation with a nucleobase (thymidine), the
naphthalimide-based boronic acid (NB) maintains its ability to change fluorescent
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properties upon sugar binding.

(b)

(a)

Figure 3.3 Fluorescent binding tests of NB-TTP with D-fructose (λex: 490 nm) in 0.1M
phosphate buffer (pH 7.4)

3.2.2 Enzymatic studies of NB-TTP
Next we studied whether this NB-TTP can be incorporated into DNA in an
enzyme-catalyzed reaction. In this study, NB-TTP was incorporated into a DNA
sequence

of

14-nt

primer

(5’-TAGCGGGTTGCTGG-3’,

calc.

MW:

4350.8)

complemented with a 21-nt template (5’-GGTTCCACCAGCAACCCGCTA-3’, calc. MW:
6336.2) through Klenow Fragment catalyzed primer extension. The primer and template
sequences were designed in such a way that the first base to be incorporated is a T,
which led to a “none-or-all” case in the extension. The results were analyzed by both
MALDI mass spectrometry and gel electrophoresis methods.
In the control reaction, full extension of the primer using natural dNTPs yielded a DNA
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with m/z: 6520.4 (calculated [M+H]+: 6519.3) as the major product peak in MALDI-MS
(Figure 3.4). The minor peak of m/z: 6850.6 could have resulted from a non-specific
extension with an extra nucleotide. In the NB-TTP (replacing TTP) reaction, primer
extension yielded a DNA with m/z: 7142.8 as the major product peak (Figure 3.5). Since
the calculated [M+H]+ is 7186.5, it is reasonable to assign the detected peak as the
deborylated NB-DNA sequence (calc. [M+H-HBO2]+: 7142.5). In order to further
determine whether the deborylation happened during primer extension reaction or during
ionization in MALDI-MS, another sample of NB-TTP extension DNA sequence treated
with H2O2 was analyzed under same condition. In this case, a new peak of m/z: 7160.6
was observed (Figure 3.6), which is assigned as the oxidative deborylated NB-DNA
sequence (calc. [M+H-HBO]+: 7158.5). Thus, it was concluded that the boronic acid of
NB-TTP was intact after incorporation into the DNA sequence and deborylation
happened during the ionization process, which is very common with arylboronic acids.
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Figure 3.4 MALDI-TOF-MS of primer extension using natural TTP
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Figure 3.5 MALDI-TOF-MS of primer extension using NB-TTP
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Figure 3.6 MALDI-TOF-MS of primer extension using NB-TTP, followed by treatment
with H2O2
The DNA from primer extension using NB-TTP was also studied using gel
electrophoresis. The 14-nt primer was labeled with 32P at the 5’-end using γ-32P-ATP and
T4 kinase (Figure 3.7, Lane 1). Negative control reactions without the Klenow fragment
(Figure 3.7, Lane 2) and without dNTPs (Figure 3.7, Lane 3) showed no full length DNA
sequence. On the other hand, positive control reactions in the presence of both the
enzyme and natural dNTPs (Figure 3.7, Lane 4) showed full length DNA. The shorter
length of DNA in the Lane 3 without dNTPs could result from the 3’→5’ exonuclease
activity of Klenow fragment.266 Primer extension using NB-TTP and three other natural
dNTPs gave a full length of DNA sequence (Figure 3.7, Lane 5). Its smear band could be
due to the interaction of the boronic acid moiety with the gel matrix or the DNA
conformation disrupted by the large naphthalimide moiety. Thus, both mass
spectrometry and gel electrophoresis results indicated that NB-TTP was recognized by
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DNA polymerase as a substrate and incorporated into DNA.
1

2

3

4

5

Figure 3.7 Primer extension analyzed on 15% PAGE:
1) primer only; 2) reaction without enzyme; 3) reaction without dNTPs; 4) reaction with
natural dNTPs; 5) reaction with NB-TTP and other dNTPs
3.3 Conclusion
In conclusion, we have successfully synthesized a naphthalimide-based boronic
acid modified TTP (NB-TTP) in totally 13 steps. The chosen boronic acid moiety
displayed long-wavelength fluorescence emission, good photo stability, and fluorescent
properties changes upon carbohydrate binding. The features were retained after
conjugating the boronic acid to TTP moiety. Enzymatic studies of the NB-TTP showed
that it can be successfully recognized by DNA polymerase such as the Klenow fragment
as the substrate. The NB-TTP incorporated DNA sequences were analyzed by both
mass spectrometry and gel electrophoresis methods, which both gave positive results
that supported each other.
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4. FLURESCENCE PROPERTY STUDIES OF NB-TTP-MODIFIED DNA
4.1 Introduction.
In addition to their critical roles in storing genomic information, DNA molecules are
also very important in the development of aptamers,267-269 nanoelectronic assemblies,270
nanosensors,271 nanoclusters,272-273 nanocomputing,274-275 and DNA rotary machine,276
to name a few.277 DNA functionalization brings in additional properties for broadened
applications.

For example, gold-nanoparticle functionalized DNA assemblies have

been used in sensor development with extraordinary sensitivity;278 and side-chain
functionalized DNA has been used in aptamer selection with improved affinity and
properties.279-283
Boronic acid-modified DNA may have applications in carbohydrate and glycoprotein
sensing as well as the construction of other DNA assemblies with unique properties. For
example, nucleic acid and peptide-templated multi-boronic acid compounds are artificial
lectin mimics;227,230,284-285 boronic acid-containing compounds have been used in the
preparation of polymers with reversible properties;286-289 boronic acid-modified proteins
can be used as lectin mimics with improved affinity and for protein purification;233 and
boronic

acid-containing

polymers

have

been

used

for

the

development

of

glucose-sensitive insulin release systems.290-291 Among them, boronic acid sensors with
both nucleic acid- and peptide-backbone structure were created in a combinatorial
fashion as described in introduction part. The difference between them lies in that nucleic
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acid-base boronolectins (NBLs) are selected from a random pool of molecular library,
while peptide-based boronolectins (PBLs) are constructed in a pattern-based detection
array method that mimics mammalian olfactory sensing system. It is almost certain that
the biomolecular backbone structure and the boronic acid positioning would affect or
even determine the glycan binding affinity and selectivity. Therefore, fundamental studies
of such in NBLs are quite important. However, so far no such studies have been reported,
probably because that the selection nature of the SELEX method doesn’t require too
much detailed structural information. However, for the purpose of rational construction of
NBLs with intrinsic fluorescence, such information could be very critical. For example,
due to the self-quenching of fluorophores and possible destabilization of sensor-target
complex by fluorophores, increasing the labeling density on nucleic acid backbone
doesn’t necessarily lead to higher fluorescence intensity and binding affinity.292-295
4.2 Results and discussion
4.2.1 Double stranded NB-DNA binding tests
After incorporating NB-TTP into the DNA sequence, we were interested in studying
whether sugar addition to the DNA solution would still cause fluorescence property
changes. Since dNTPs and oligonucleotides are known to quench fluorescence,296-298
the retention of NB-TTP’s fluorescent property in DNA was uncertain. The DNA was
synthesized in the same method of using Klenow fragment. For every full-length double
stranded DNA, only one NB-TTP was incorporated for 14nt-primer extension with the
21-nt template. After purification with membrane filtration and ethanol precipitation, the
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NB-DNA was dissolved in 0.1M phosphate buffer (pH 7.4) to make a 5 μM solution,
which was based on the theoretical yield of DNA synthesis. Fructose concentration was
increased from 1 to 100 mM. The fluorescence intensity of NB-DNA increased by about
1.5-fold upon fructose addition (λex: 490 nm, λem: 540 nm) (Figure 4.1). Hence, it showed
that even after incorporation into DNA sequence, the boronic acid fluorescence
properties were still well retained. This is the very first example of side-chain
functionalized DNA showing intrinsic fluorescent property changes upon sugar binding.
Similar modified DNA will be very useful in the synthesis of DNA molecules/assemblies
for various applications including sensing of carbohydrates, glycolipids, and
glycoproteins.

Figure 4.1 Fluorescent binding tests of NB-DNA (0.5 μM) with D-fructose in 0.1M
phosphate buffer (pH 7.4)

Based on preliminary NB-DNA fluorescence binding studies, more DNA sequences
are designed to further analyze factors affecting DNA fluorescent properties. To minimize
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the changes of the DNA sequences, Templates 1-7 were designed in a way of having two
adenosine on the 5’-end end separated by 0-6 bases while the rest of bases were kept
the same (Table 4.1). The 21nt-template used for previous enzymatic studies were
designated as Template 0 for control. Thus, for primer extensions, two NB-TTPs would
be incorporated to the 14nt-primer with 0 to 6 bases of distance spacing. After that, the
double stranded bisboronic acid NB-DNA would be tested of its fluorescence properties
with the model carbohydrate fructose.
Primer
Template 0
Template 1
Template 2
Template 3
Template 4
Template 5
Template 6
Template 7

3’-GGTCGTTGGGCGAT-5’
5’-GGTTCCACCAGCAACCCGCTA-3’
5’-GGTTCCAACCAGCAACCCGCTA-3’
5’-GGTTCACACCAGCAACCCGCTA-3’
5’-GGTTACCACCAGCAACCCGCTA-3’
5’-GGTATCCACCAGCAACCCGCTA-3’
5’-GGATTCCACCAGCAACCCGCTA-3’
5’-GAGTTCCACCAGCAACCCGCTA-3’
5’-AGGTTCCACCAGCAACCCGCTA-3’

Table 4.1 Designed DNA template sequences for primer extension reactions

Before the carbohydrate-binding test, it was necessary to verify the NB-TTP
enzymatic incorporation efficiency again. Even thought previous chapter has already
demonstrated that single NB-TTP could be successfully incorporated through enzymatic
DNA polymerization, the bulkiness of the first incorporated naphthalimide moiety on DNA
could impose a possible steric hinderance to the incorporation of the second NB-TTP.
Fortunately, from the gel electrophoresis results, it can be seen that full-length
extensions were achieved with all the DNA templates as the major bands for each lane
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(Figure 4.2). Interestingly, the positive control using a NB-TTP/natural TTP mixture
showed two fully extended DNA bands with Template 1(Figure 4.2, Lane 3). Due to the
larger molecular weight of NB-TTP than that of TTP, the faster moving band could be
assigned as full-length DNA of incorporation of two TTP while the slower moving band
could be full-length DNA with the incorporation of at least one NB-TTP. The smear of the
full length NB-DNA bands (Figure 4.2, Lane 4-10) were probably due to the interactions
of boronic acid with gel matrix or the DNA conformation disrupted by the large
naphthlimide moiety, which corresponded well with previous enzymatic study PAGE
results (Figure 3.8).
1

2

3

4

5

6

7

8

9

10

Figure 4.2 15% PAGE analysis of primer extensions with Templates 1-7
1) primer only; 2) reaction without dNTPs; 3) Template 1 extension with NB-TTP +TTP; 4)
Template 1 extension with NB-TTP; 5) Template 2 extension with NB-TTP; 6) Template 3
extension with NB-TTP; 7) Template 4 extension with NB-TTP; 8) Template 5 extension
with NB-TTP; 9) Template 6 extension with NB-TTP; 10) Template 7 extension with
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NB-TTP

The same model carbohydrate, fructose, was chosen as the model for the fluorescent
property tests. Double stranded NB-DNA (NB-dsDNA) sequences were generated
through primer extension reactions with primer/template ratio of 1:1 and no heat
denaturation before the binding tests. Template 0 was used as the control sequence.
Fluorescence intensity increases of the various NB-dsDNA sequences upon addition of
0.1 M fructose examined. From the testing results (Figure 4.3), it could be seen that DNA
5 showed significantly higher fluorescence intensity increase than the control (DNA 0),
while DNA 7 showed lower fluorescence increase than the control. Meanwhile, the
comparison of any other two DNA sequences showed no significant differences due to
the relatively large experimental errors. Therefore, it indicates at least to some extent
that the number of boronic acids, the distance spacing between them and the DNA
sequence do contribute to difference observed in binding. However, those DNA
sequences were not purposely designed to have significant intrinsic difference in
fructose binding pattern. This is only a preliminary proof-of-concept experiment study.
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Figure 4.3 Fluorescent binding tests of NB-dsDNA (Template 0~7) with D-fructose (λex:
490 nm) in 0.1M phosphate buffer (pH 7.4)

4.2.2 Single stranded NB-DNA binding tests
For the sequence-dependent fluorescence studies of the single stranded DNA, three
disaccharides, lactose, maltose and sucrose were chosen as the model carbohydrates.
Single stranded NB -DNA (NB-ssDNA) was created through primer/template ratio of 3:1
and heat denaturation before binding. It was expected that the bis-boronic acid on DNA
backbone would have more discrimination towards disaccharides with relatively larger
molecule and the ssDNA could provide more flexibility in the recognition process. The
test results (Figure 4.4) showed that DNA 1 and DNA 5 have significant preference of
lactose to maltose and sucrose while others didn’t. In addition, DNA 5 still showed higher
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fluorescence intensity increase upon fructose binding than DNA 0 and DNA 7, which was
similar to the result of dsDNA binding tests (Figure 4.3). Thus, even though the
differences between the signal intensity increase are relatively small (<30%), they were
indeed reproducible results. Of course, the nature of boronic acid itself still played the
major role in carbohydrate recognization in this case, as compared to the effect of DNA
sequences.

Figure 4.4 Fluorescent binding tests of NB-ssDNA with carbohydrates (λex: 490 nm) in
0.1M phosphate buffer (pH 7.4)

4.2.3 Optical Properties Comparison Between Naphthalimide (Nap), aNap, NB,
NB-TTP, NB- dsDNA and NB-ssDNA
Throughout the whole process of systematic modification of the fluorphore
4-amino-1,8-naphthalimide (Nap), the optical properties of Nap has been changed along
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each modification step (e.g. λmax and Abs of UV absorbance, λmax and emission intensity
of fluorescence). Thus, it would be necessary to evaluation the optical effect of each
modification step. Thus, alkylated 4-amino-1,8-naphthalimide (6, aNap), NB (7), NB-TTP,
NB-dsDNA0, NB-TTP-dsDNA5 and NB-TTP-ssDNA5 were chosen to evaluate the effect
of alkylation, borylation, TTP conjugation, DNA incorporation, on the optical properties of
Nap (Table 4.2).

UV λmax
UV Abs at λmax
Fluorescence
λmax
Fluorescence
Intensity at λmax
Integrated
Fluorescence
Intensity
Quantum yield (Φ)

NB-

NB-

NB-

dsDNA0

dsDNA5

ssDNA5

495±1

473±1

468±1

470±1

0.020±

0.028±

0.012±

0.019±

0.019±

0.001

0.001

0.001

0.001

0.001

0.001

541±1

529±2

574±1

572±1

531±3

535±1

533±2

480±6

186±4

235±8

478±11

878±102

610±23

852±58

35241±

13128±

16838±

36693±

71971±

54586±

72029±

387

156

537

786

7430

2035

4917

0.013±

0.008±

0.007±

0.011±

0.049±

0.023±

0.031±

0.004

0.003

0.002

0.003

0.015

0.007

0.009

Nap

aNap (6)

NB(7)

NB-TTP

434±1

445±1

490±1

0.022±

0.013±

0.001

Table 4.2 Optical effect of Nap modifications
(Experiments in triplicate were conducted in 0.1M phosphate buffer pH 7.4, with 0.01% DMSO (for Nap
and aNap), or 0.01% MeOH (for NB(7)); [Nap] = [aNap] = [NB] = [NB-TTP] = 2 μM; NB-DNA was prepared
in the same way as for binding tests, theoretical [NB-dsDNA0] = [NB-dsDNA5] =[NB-ssDNA5] = 1.4 μM)
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From the results listed in Table 4.2, it can be seen that the magnitude of the intensity
increase of both UV absorbance (2-fold) and fluorescence (3-fold) were decreased after
alkylation of Nap. Besides, alkylation of Nap resulted in a red-shift by about 10 nm in its
UV λmax and a blue-shift by about 10 nm in fluorescence λmax. In contrast, the borylation
of aNap increased both the UV (1.5-fold) and fluorescence (1.3-fold) intensities, while at
the same time resulted a λmax red-shifted of about 40 nm in both UV and fluorescence,
Conjugation of NB to TTP moiety didn’t affect UV significantly, but increased the
fluorescence intensity by about 2-fold. Such results indicated that increasing
hydrophobicity (alkylation) of Nap could lead to a decrease in both UV and fluorescence
intensities, while increasing hydrophilicity (borylation and TTP conjugation) could lead to
UV and fluorescence intensity increases (Fig 4.5).

Figure 4.5 Fluorescent profiles of Nap, aNap, NB and NB-TTP at 2 μM in 0.1 M
phosphate buffer pH 7.4 with 0.01% DMSO (for Nap and aNap) or 0.01% MeOH (for
NB(7))
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After chemical modification, the optical effect of DNA incorporation of NB-TTP was
studied. Using DNA sequence 0 with only one T incorporation, it was surprising that the
fluorescent intensity of NB-TTP increased by more than 2-fold after DNA incoporation.
This could be partially due to the further increased hydrophilicity of NB. Both UV and
fluorescence λmax blue-shifted (20 nm for UV, 40 nm for fluorescence) after DNA
incorporation. It should also be noted that the quantum yield of NB-TTP also increased
by more than 3-fold after incorporation into dsDNA0. However, NB-TTP incorporation
into DNA sequence 5 with incorporation of two T bases didn’t increase the fluorescent
intensity further. Instead, it was decreased by 1.25-fold as compared to that of
NB-dsDNA0. This phenomenon was probably due to the self-quenching effect of the two
neighboring NB moieties on the same dsDNA sequence. This assumption was further
supported by the fact that the fluorescent intensity of NB-ssDNA5 was 0.4-fold higher
than NB-dsDNA5, probably because of decreased self-quenching effect on more flexible
ssDNA backbone. The fluorescent profile comparison of NB-TTP DNA incorporation is
shown in Fig 4.6.
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Figure 4.6 Fluorescent profiles of NB-TTP (2 μM), NB-dsDNA0, NB-dsDNA5 and
NB-ssDNA5 (1.4 μM) in 0.1 M phosphate buffer pH 7.4

In all, the effect of chemical modification on fluorphore Nap was tested and evaluated.
The general trend is that increasing hydrophobicity of Nap would decrease its
fluorescent intensity, while increasing its hydrophilicity would increase its fluorescent
intensity. The self-quenching effect of two neighboring NB on the same DNA backbone
was observed, and the effect could be partially decreased by melting dsDNA into ssDNA.

4.3 Conclusion
In conclusion, the enzymatic activity of NB-TTP as DNA polymerase substrate has
been further confirmed by gel electrophoresis. Even for two NB-TTPs to be continuously
incorporated, full-length DNA polymerization was obtained. Furthermore, fluorescent
binding studies indicated that binding affinity or selectivity of DNA-based boronic acid
sensors toward carbohydrates could indeed be affected by the number of boronic acid
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moieties, the spacing between them and DNA sequence to certain extent. Furthermore,
the spectroscopic effects of chemical modification on Nap and DNA incorporation of
NB-TTP were also evaluated. It was proposed that hydrophobicity/hydrophilicity change
of Nap could be the reason of the fluorescence wavelength shift and intensity change.
The self-quenching effect of two NB moieties on the same DNA backbone was also
observed and such effect could be partially alleviated by dissociating dsDNA into ssDNA.
Again, the initial DNA sequence (14nt-primer/21-nt template) was almost a random
choice and modified with minimal changes to have two NB-TTPs incorporated. These
preliminary proof-of-concept studies could provide valuable and insightful information for
future rational design of nucleic acid-based boronolectins (NBLs) with intrinsic
fluorescence change towards carbohydrates, glycoprotiens or glycolipids.
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5. CELL IMAGING STUDIES USING NB-TTP
5.1 Introduction
Inspired by the Hageman’s boronic acid-cell surface labeling studies196-198 and
encouraged by our group’s success in developing fluorescent diboronic acids
recognizing sialic acid on tumor cell membrane,142,199 further work to explore the
potential applications of the synthesized NB-TTP was undertaken. There are several
considerable advantages of utilizing NB-TTP to label cells. First, the long excitation and
emission wavelengths (λex: 490nm, λem: 540 nm) of NB-TTP fluorophore avoid the
potential problems of photodamages and high background noises commonly caused by
ultraviolet (UV: 200-400 nm) illumination.299-300 Besides, NB-TTP also has very close
excitation/emmission wavelengths to FITC filter set (495 nm/520 nm), which makes cell
labeling easily observable under fluorescent microscope. Second, napthalimide-based
compounds have previously been tested in cancer301-304 and virus infection305-307 therapy,
and cell-imaging study,308-312 but none of those had boronic acid moieties attached to.
The success of incorporating boronic acid into cells could provide valuable information
for other therapeutical research such as living cell glycan detection308 or boron-neutron
capture therapy (BNCT).162,313-315 Third, with the TTP-moiety attached to the fluorophore,
we expected that there be the possibility of the DNA duplication machinery of dividing
cells to incorporate NB-TTP into their genomic sequences, since it is known that NB-TTP
is recognized as DNA polymerase substrate in in vitro studies.
However, there are also several issues that need to be taken into consideration
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before NB-TTP cell labeling experiments. Since the triphosphate group of NB-TTP is
negatively charged under physiological pH condition, the cell permeability of NB-TTP
could be a hurdle. Also, the cytotoxicity of NB-TTP is unknown, given the large planar
structure of the napthalimide moiety is found in anti-cancer reagents.301,303-304 Three
possible scenarios were expected of the labeling studies: 1) NB-TTP could not enter into
the cell, but stay outside and label the cell-surface glycans with the boronic acid moiety;
2) NB-TTP could enter into the cell cytoplasma due to its amphiphilic nature, but could
not pass the nuclear membrane; 3) NB-TTP could diffuse across both the cellular and
nuclear membrane, and even accumulate inside the nucleus either through incorporation
into genomic DNA , intercalation between DNA base through stacking, or simply staining
chromatin proteins like histone through ionic interactions. All those possible results could
provide valuable information for further experimental design. In this chapter, HeLa cells
were chosen as the labeling target of NB-TTP. Nap and boronic acid 9 (Scheme 3.1),
with no TTP moiety, was used as the control labeling compound.

5.2 Results and discussion
Nap, NB9 and NB-TTP at various concentrations (50, 25, 12.5, 6.25, 0 μM) were
added into cell culture medium containing HeLa cells in a 24-well plate with coverslips.
Coverslips from the wells were taken at different time intervals (2, 5, 9, 17, 24 h), fixed to
slides and observed under the Zeiss Axiovert 400M inverted epifluorescence microscope
using FITC filter. From the cell imaging pictures taken (Table 5.1), it was observed that
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shortly after 2 h of incubation, all compounds (Nap, NB9 and NB-TTP successfully
labelled HeLa cells. As expected, Nap labeled HeLa in a whole-cell pattern with intense
fluorescence. This might be because of that Nap has smaller molecular weight and high
hydrophobicity, which makes it capable of quick diffusing through cellular and nuclear
membrane into cytoplasma and nuclear area. A comparison of labeling results between
50 μM (Table 5.1 c and e) and 25 μM (Table 5.1 d and f) suggested a
concentration-dependent staining pattern. At this stage, however, no clear distinction of
the labeling style between control (NB9) and NB-TTP could be seen since both
compounds stained the cells in a homogeneous way and the fluorescence intensities in
cytoplasm and in nucleus were comparable. After 5 h of incubation, no significant change
of Nap labeling pattern has been observed, but NB9 seems to accumulate in cytoplasm
more than in nucleus (Table 5.2 c and d) while NB-TTP still labeled cells in a
non-selective way (Table 5.2 e and f). After 9 and 17 h, it was clear that the NB9 was
significantly more localized in the cytoplasm (Table 5.3 c; Table 5.4 c) while the nucleus
showed much lower fluorescence staining. In contrast, NB-TTP showed much more
accumulation in the nucleus area with some punctuate-labeling pattern (Table 5.3 e;
Table 5.4 e). Similar punctuate-labeling pattern was observed with Nap labeling
consistantly (Table 5.1-5.5 a and b). From the imaging results after 24 h incubation, it
could be seen that NB-TTP still labeled the cell nucleus with higher fluorescence
intensity (Table 5.5 b) while control compound showed few surviving cells (Table 5.5 e).
Besides, it also indicated that NB-TTP was stable enough to last for at least 24 h under
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cell incubation condition with persistent staining pattern.
Table 5.1 HeLa cell imaging 2 h after incubation
[exposure time 2.54s with FITC filter 495/520]

(a) Nap 50 μM

(b) Nap 25 μM

(c) NB9 50 μM

(d) NB9 25 μM

(e) NB-TTP 50 μM

(f) NB-TTP 25 μM
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Table 5.2 HeLa cell imaging 5 h after incubation
[exposure time 2.54s with FITC filter 495/520]

(a) Nap 50 μM

(b) Nap 25 μM

(c) NB9 50 μM

(d) NB9 25 μM

(e) NB-TTP 50 μM

(f) NB-TTP 25 μM
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Table 5.3 HeLa cell imaging 9 h after incubation
[exposure time 2.54s with FITC filter 495/520]

(a) Nap 50 μM

(b) Nap 25 μM

(c) NB9 50 μM

(d) NB9 25 μM

(e) NB-TTP 50 μM

(f) NB-TTP 25 μM
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Table 5.4 HeLa cell imaging 17 h after incubation
[exposure time 2.54s with FITC filter 495/520]

(a) Nap 50 μM

(b) Nap 25 μM

(c) NB9 50 μM

(d) NB9 25 μM

(e) NB-TTP 50 μM

(f) NB-TTP 25 μM
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Table 5.5 HeLa cell imaging 24 h after incubation
[exposure time 2.54s with FITC filter 495/520]

(a) Nap 50 μM

(b) Nap 25 μM

(c) NB9 50 μM

(d) NB9 25 μM

(e) NB-TTP 50 μM

(f) NB-TTP 25 μM
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As an overview of the cell imaging profiles of Nap, NB9 and NB-TTP, it can be
concluded that labeling was a concentration- and time-dependent process for NB9 and
NB-TTP, while Nap showed quick and consistant labeling pattern with no significant
difference between two used concentrations. Initially, good membrane permeability of
Nap allowed it to diffuse into the cell cytoplasm and nucleus area quickly and uniformly.
For the less hydrophobic NB9 and NB-TTP, their permeability and diffusion rate was
much slower than Nap. Thus, it took longer time for NB9 and NB-TTP to develop each
labeling-pattern.

Since the triphosphate group of NB-TTP is highly hydrophilic, the

napthalimide moiety probably contributes significant hydrophobicity to grant the
amphiphilic molecule enough lipid solubility. As the incubation time increased, NB-TTP
showed a better preference for cell nucleus accumulation while control was primarily
localized at cytoplasm area. Since the major difference between NB-TTP and control is
the thymidine triphosphate moiety, one plausible way to explain the labeling behavior
difference could be the selective incorporation of NB-TTP as a TTP analogue by DNA
duplication machinery during the cell mitosis process. However, further experiment
shows that the extracted genomic DNA from NB-TTP-labeled HeLa cell had little
fluorescence (Figure 5.1 a) compared with the crude protein precipitation fraction (Figure
5.1 b). The NB9-labeled cell fractions showed similar result. Thus, the HeLa nucleus
could be stained through other mechanisms, e.g. ionic interactions between negatively
charged NB-TTP with positively charged histones, which could also explain the
punctuate-labeling pattern in some labeled cells (Table 5.3 e). Because the NB-TTP
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penetration into the nucleus was not a major problem, there could be an enhanced
chance for NB-TTP incorporation into genomic DNA by suppressing the natural TTP
level, such as addition of thymidylate synthase inhibitor, e.g. Raltitrexed. To further
confirm that NB-TTP indeed labeled the cell nucleus, HeLa cell nuclei isolation was
performed according to published protocol.254 Obviously, bright rounded nucleus could
be seen from the NB-TTP-labeled cells extraction (Figure 5.2 b), while the
control-labeled cells didn’t show such (Figure 5.2 a).

(a)

(b)

Figure 5.1 Fluorescence measurement of HeLa cell lyses fractions
(λex: 490 nm, in 0.1 M pH 8.0 phosphate buffer)
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(a) NB9

(b) NB-TTP

Figure 5.2 HeLa cell nuclei isolation [exposure time: 2.54s with FITC filter 495/520]

5.3 Conclusion
In conclusion, the synthesized NB-TTP has been found to be cell nucleus- labeling
fluorescent reagent with good cell-membrane permeability. Compared with the control
(boronic acid 9), NB-TTP showed significant accumulation inside cell nucleus area. The
HeLa cell culture was consistently stained by NB-TTP up to 50 μM for at least 24 h. Even
though the detailed labeling mechanism was still unclear, the experiment served as a
good starting point for the design and synthesis of cell imaging reagent using a similar
strategy. Furthermore, the successful demonstration of the feasibility of incorporating
boronic acid into living cells may even provide some insight into in vivo carbohydrate
detection and distribution study in the future.
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6. MAJOR FINDINGS, SIGNIFICANCES, POTENTIAL APPLICATIONS AND
FURTHER IMPROVEMENTS
The major contribution of the work in this dissertation was the successful synthesis of
a naphthalimide-based boronic acid-modified TTP (NB-TTP). The challenges in the
multiple synthetic steps lay in the instability of the boronic acid (towards light, air, heat,
pH and metal ions) and the triphosphate product (towards heat and pH). In addition, the
high polarity of both boronic acid and triphosphate compounds made them very hard to
purify. It was only through careful handling of all materials and design of the synthetic
strategy, together with condition optimization after trial and error that the desired final
product (NB-TTP) was obtained. It was accomplished in a total of 13 steps to yield the
final product of MW > 1kD.
The signicance of NB-TTP was its intrinsic longwavelength fluorescence intensity
increase upon carbohydrate binding. It was surprising to find that after conjugation of NB
towards TTP and incorporation of NB-TTP into DNA sequence, the fluorescence
intensity and quantum yield of NB was further increased, rather than being quenched.
The binding studies of NB-DNA with fructose indicated that it is the very first example of
modified DNA showing intrinsic fluorescent changes upon sugar binding and such
changes do not rely on FRET. Thus, it was forseeable that NB-based fluorescent DNA
sensors could be developed through appropriately selected DNA sequences or scaffolds
with high affinity and selectivity towards specific glycan. The beauty of this new type of
sensor is that the binding signal is increased fluorescenct intensity at a visible
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wavelength, which made observation and recording convenient.
Besides its potential application in DNA-based sensor development, NB-TTP might
also be used in fluorescent cell imaging. From the HeLa cell imaging results, it seemed
that the boronic acid moiety of NB prevent it from entering the nuclear area as comared
with Nap. In contrast, NB-TTP showed significant accumulation in cell nucleus. The cell
lysis fractionation results suggested that the labeling pattern of NB-TTP was not resulting
from genomic DNA incorporation, which might be due to the large molecular size and
cytotoxic effect of NB. Despite of that, it certainly opened the door of the possibility that
by choosing a smaller boronic acid moiety with less cytotoxic effect, a new B-TTP may
function as the probe for changes in the nuclear environment, nuclear imaging, and cell
division genomic DNA tracing.
In all, the work accomplished was a systematic preliminary study of fluorescent
boronic acid modified nucleic acid’s potential applications. Further exploration in this field
might require more efforts in developing an improved version of NB-TTP, which should
demonstrate better water solubility, higher fluorescence intensity, higher quantum yield,
more obivious fluorescence changes upon analyte binding, etc. In order to do that,
careful selection of a new boronic acid moiety is required. This boronic acid should meet
the previously described criteria. The same rule also applies to cell imaging applications
of boronic acid-modified nucleic acid.
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XIAOCHUANG_YXC_G_ACCUMASS_ESI_NEG_WANG_060509 96 (1.782) AM (Cen,3, 80.00, Ar,6500.0,554.26,0.00); Cm (81:96)

1: TOF MS ES3.58e4

564.2310

100

578.2449

*
554.2615

%
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m/z
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132

50%MeOH+0.5%NH3

16:21:0905-Jun-2009

XIAOCHUANG_YXC_H_ESI_NEG_WANG_060509 191 (3.551) Cm (181:191)

1: TOF MS ES2.14e3

492.3

100

%

478.3

464.3

385.0

265.0
273.0

333.0

303.0

508.3

357.0
366.9
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0
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289.0

300

320

340

360

380

400

522.3

425.0

420

440

460

480

500

520
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m/z
700

133
50%MeOH+0.5%NH3 LeuEnk as ITSD 554.2615 Da

16:36:0805-Jun-2009

XIAOCHUANG_YXC_H_ACCUMASS_ESI_NEG_WANG_060509 153 (2.840) AM (Cen,3, 80.00, Ar,6500.0,554.26,0.00); Cm (147:153)

1: TOF MS ES3.31e3

*;554.2615

%

100

464.1796

576.2440
478.2029
492.2142
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0
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m/z

134

50%MeOH+0.5%NH3

16:11:5005-Jun-2009

XIAOCHUANG_YXC_I_ESI_NEG_WANG_060509 31 (0.574) Cm (28:32)

1: TOF MS ES381

547.3

100

%

561.3

270.9

286.9
299.9

575.3

591.3
529.3

351.0
316.9
335.0

0
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320
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508.3

500
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647.3
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669.3
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m/z
700

135
50%MeOH+0.5%NH3 LeuEnk as ITSD 554.2615 Da

16:09:1805-Jun-2009

XIAOCHUANG_YXC_I_ACCUMASS_ESI_NEG_WANG_060509 7 (0.130) AM (Cen,3, 80.00, Ar,6500.0,554.26,0.00); Cm (4:8)

1: TOF MS ES4.76e3

547.1912

100

%

561.2071

*
554.2615

575.2200

552.2035

564.2220

0
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566.2409
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m/z

136

in 50%MeOH

16:30:46

YXC_III_81_ESI_NEG_WANG_040308 487 (4.818) Cm (452:490)

TOF MS ES1.54e3

1032.3

100

%

1033.3

1031.3
1034.3

1054.3

1040.3

1113.3

1050.3
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0
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1112.3
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1200

m/z

137

50%MeOH+50%H2O+0.5%NH3, Naformate as standard

16:20:0011-Aug-2009

XIAOCHUAN_YXC_N_TTP_ESI_NEG_WANG_081109_04 194 (3.598) AM (Cen,3, 80.00, Ar,6500.0,1064.81,0.00); Sm (SG, 2x3.00); Cm (97:199)

1: TOF MS ES3.23e3

1032.2321

100

1054.2092

1134.1755

952.2639

%

1112.1940
1076.1965

1156.1544
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928.8410
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